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Abstract
We wanted to develop a system that combines the spatial control of
photoactivation and control of translation to build a tool to spatially control
translation in neurons. This kind of tool could be used to investigate the role of
spatially controlled translation of any protein in neural behavior. In this way the
development and growth of neural processes could be studied to elucidate the
mechanisms for spatially sensitive events such as pathfinding, repair, or longterm potentiation.
Chemically induced dimerization was used to install a switch into the
activation of translation for specific genes. An abscisic acid (ABA) dependent
dimerization of the proteins PYL and ABI was engineered to control the proximity
of the translation machinery to an RNA sequence by fusing the C-terminus of

iv

eIF4G to PYL and fusing the MS2 coat protein to ABI. This produced ABA
dependent translation of a reporter gene downstream of the MS2 stem loop. The
expression of the reporter protein was low without ABA and increased within
hours of addition of ABA.
ABA dependent dimerization of two proteins, PYL and ABI, was
engineered to be photoactivatable. ABA was caged with protecting groups,
DMNB and DEACM, that can be cleaved by light. This was used to control the
activation of biological events with light. We were able to achieve temporal
control over the activation of biological activity, but were unable to spatially
control this activity.
The photoactivation of ABA dimerization could possibly be used in
combination with the activation of translation. This could provide optical control
over translation and possibly provide a tool that is capable of studying translation
on a sub-cellular scale.
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Chapter 1 – Controlling Translation and Optogenetics
Protein translation is highly regulated in the cell to control the specific time
and place that a protein is produced. The regulation of translation to a specific
location is particularly important for neural growth. In order to investigate this
process we must possess a tool that is capable for sub-cellular activation of
translation for specific transcripts. There are tools for controlling the expression
of specific transcripts, but none that have control on the sub-cellular scale.
The field of optogenetics has been used to induce signaling on a subcellular level using precise activation with light, and maybe a similar technique
could be applied to activate translation.

Optogenetics is the use of light

combined with the expression of a gene that encodes a photo responsive protein
system.

Combining optics and genetics provides greater control over the

activation of the system.
Photo inducible dimerization of proteins is a branch of optogenetics that is
highly adaptable to controlling biological events that depend on the proximity of
two components.

Engineering photo inducible dimerization to control protein

translation could provide the ability to investigate the role of a protein in a
spatially sensitive natural process.

1

1.1 Sub-Cellular Control of Translation

Introduction
There are two main parts to gene expression: transcription and translation.
The transcription of the DNA into RNA is heavily regulated by the specific
condition of the cell. Transcription of any gene can be controlled in time, but
since all of transcription occurs in the nucleus, it is generally not a spatially
controlled process. The time of translation of an mRNA can be controlled, but in
addition translation can be limited to a specific sub-cellular location.

The

production of a given protein can be restricted to a subcellular region in order to
fulfill a very localized purpose.
There are general tools for repressing all cellular translation with drugs
such as rapamycin (1).

There are even tools for activating translation of a

specific transcript (2) and degrading specific sequences (3). A tool that has
spatial control of translation of a specific transcript is necessary to investigate the
natural functions of localized mRNA in cells. Spatially sensitive translation could
be further understood if there were more tools for studying it. There is a need for
a tool that will allow subcellular manipulations to learn about the function of
localized translation (4).

2

Importance of Spatially Controlled Translation
There are ways to control the global translation in a cell that tune the level
of activity depending upon the conditions. There are also ways a cell can control
translation on a more transcript specific level. Global control of translation is
achieved by modifying the activity of translational machinery.

While mRNA

specific control is modulated through the interactions of the mRNA sequences
and proteins that bind it.
Translational control is extremely important in the oocyte and early
embryo. Early embryos are often transcriptionally silent, but employ a rapidly
changing cast of proteins to regulate development processes. Localized mRNAs
are seen in many cell types and play a role in establishing polarity and structure
(5).

The accumulation of different mRNAs is seen at distinct stages in

development (5), and it was found that 71% of mRNA’s are expressed in spatially
distinct patterns in early embryos, Figure 1.1 (6).

Figure 1.1 Fluorescent in situ hybridization of mRNA during early embryogenesis in Drosophila
shows the localization of different transcripts. (6)

3

Localized mRNA causes the accumulation of a protein at the destination
of the transcript.

This restricts the expression of a protein to a subcellular

location, and it can be temporally controlled with stimuli to produce rapid
responses. The localization of a transcript allows the cell to be efficient for the
specific expression of a protein.
Localized translation is used by cells to establish polarity in embryos. The
Xwnt-11 mRNA initiates establishment of the body axes in Xenopus (7). Its
spatially controlled translation results in the accumulation of the protein along the
dorsal-ventral axis (8). The mRNA for oskar and nanos are specifically
expressed in the posterior in Drosophila embryos (9-10). Their translation is
controlled by a host of RBPs such as, Bruno, Staufen, and Vasa (12-13). The
Nanos and Oskar proteins in turn regulate the expression of other transcripts.
The regulation of translation in a single cell is crucial for the development of
polarity for the entire organism.
Neurons control the translation of many proteins spatially and temporally
through complex mechanisms that allow them to follow guidance cues or avoid
repulsive cues.

Studies using microarrays have shown that thousands of

transcripts are present in axons and dendrites (14). Synaptic activity controls the
distribution of mRNAs and the RNA binding proteins (RBPs) present in the
neuronal processes (15).

Localized translation at synapses establishes what

proteins are produced, which is important for the specific activity of the synapse.
Local translation occurs at synapses during long-term potentiation and is
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triggered by trans synaptic chemical signals (16). Localized translation is
essential for the function and growth of neurons.
Several mRNAs from cytoskeletal proteins including β-actin, peripherin,
vimentin, γ-tropomyosin 3, and cofilin 1 are present in the axon of dorsal root
ganglia (DRG) neurons (17). Also found in the axons are mRNAs for heat shock
proteins,

endoplasmic

reticulum

proteins,

proteins

associated

with

neurodegenerative disease, anti-oxidant proteins, and metabolic proteins (17).
Treatment with neurotrophins increased the levels of cytoskeletal mRNAs only by
selectively increasing transport to the axon (17).

In addition, repulsive cues

induce the axonal translation of cytoskeletal regulators, Rho A and cofilin, to
control actin polymerization (18). The localized production of proteins is rapid
and occurs in a matter of minutes and allows the cell to rapidly react to changes
in its environment.

Mechanisms of Regulating Translation
The translation initiation complex is made up of many proteins. These
proteins function to bring the mRNA into proximity with the ribosome so that
translation can begin.

There is a translation initiation complex composed of

eukaryotic initiation factor proteins, such as eIF4E, PABP, eIF4G, eIF4A and
eIF3. The mRNA circularizes because the cap binding protein, eIF4E, and the
poly A binding protein, PABP, will both bind to eIF4G to bring the head and tail
together. The translation initiation factor eIF4G is the connection between the
initiation factors that bind the mRNA, PABP and eIF4E, and the factors that bind
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the small subunit of the ribosome, eIF4A and eIF3, Figure 1.2.

The 40S

ribosomal subunit is recruited to the initiation complex. Once it is bound it scans
along the RNA until it reaches the first start codon, AUG.

Figure 1.2. Translation of an mRNA requires the translation initiation complex. Regulation of
translation occurs by interrupting the formation of the complex. RNA binding proteins are capable
of inhibiting translation and localizing the transcript.

Activation of translation occurs through

inhibition of the repressor protein and release of the mRNA.
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The factor eIF4E is a critical regulator for cell growth, development and
differentiation (19). Phosphorylation activates the proteins ability to participate in
translation and is induced by growth factors, hormones, and mitogens (19).
Dephosphorylation occurs in response to serum deprivation, viral infection, and
heat shock (19), which globally suppresses cap-dependent translation to protect
the cell. The phosphorylation of eIF4E is often used to spatially control the
translation of transcripts in a given area, but is not specific to the mRNA it
activates.
One way that cells control translation of specific transcripts is to have a
RBP that binds a specific mRNA and localizes it to a given subcellular
compartment, Figure 1.2.

The RBPs block translation of an mRNA until it

reaches the proper destination (20). The sequences that regulate localization
and repression are most often found in the 3’ untranslated region (UTR) of the
mRNA (21). Repressors often target the binding of eIF4G and eIF4E, Figure 1.2.
A repressor may bind eIF4E to block eIF4G (22) or bind eIF4G to block its ability
to recruit the translation complex (23).
The eventual release of the repressors results from a spatially restricted
activator protein. The translation activation has been shown to be a result of
spatially controlled kinases that inhibit the translational repression through
phosphorylation (20).

Spatially controlled proteins that bind the translation

repressors are also able to cause the release of the mRNA and activation of
translation (24).
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Localized mRNAs are translated in neurons in response to synaptic
activation and guidance cues (25). The guidance cue is received as a signal and
transmitted through receptor-coupled kinases, ERK and mTOR (25). The kinase
mTOR phosphorylates the eIF4E binding protein 1 (4E-BP1), which causes the
dissociation of the 4E-BP1 and eIF4E to activate the translation machinery (2627). Rapamycin, an FDA approved drug, inhibits translation by preventing the
phosphorylation of 4E-BP1 (28). 4E-BP1 is a small protein that competes with
eIF4G for binding to eIF4E and prevents the formation of the initiation complex
(29). eIF4E and 4E-BP are both phosphorylated in growth cones induced by
guidance cues (25). Nerve growth factor and netrin-1 induce a rapid increase in
4E-BP1 phosphorylation in growth cones (30).
RBPs bring together RNA-protein complexes to form RNA granules that
prevent translation (31). Some RBPs, such as cytotoxic granule-associated RNA
binding protein (TIA-1), TIA-1 related protein (TIAR), GAP SH3 domain binding
protein (G3BP), are responsible for reversible aggregation and contain glutamine
and asparagine rich domains that readily aggregate to form RNA granules.
There are three different kinds of granules: ribonucleoprotein particles (RNP) that
function in the transport and the storage of mRNAs, stress granules (SG) that
sequester nonessential mRNAs to promote translation of stress response
proteins, and processing bodies (P-bodies) that regulate degradation of mRNAs
(31). P-bodies often contain miRNA machinery and decapping enzymes (32).
Survival motor neuron (SMN) protein is important for the formation of stress
granules (33) and is found in RNP complexes with fragile X mental retardation
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protein (FMRP) (34). FMRP and the RBP Pumilio function in dendritic transport
and repression of mRNAs (35). The primary components of SG are the proteins
TIA-1, TIAR, G3BP and SMN, but other disease related proteins associate with
SG as they expand such as FMRP, fused in sarcoma (FUS), TAR DNA binding
protein-43 (TDP-43), and ataxin-2 (36).
The most well studied RBP is zipcode binding protein 1 (ZBP1) which
regulates the β-actin mRNA by directing its localization and expression through
binding to a sequence in the 3’UTR of the mRNA (37). β-actin mRNA has been
found localized to axonal growth cones using in situ hybridization (38). ZBP1
localizes it to regions of high actin polymerization (20).

ZBP1 prevents

translation of the mRNA until it reaches the periphery of the cell where Src
phosphorylates ZBP1 and releases the mRNA for translation (20).
FMRP is known to mediate mRNA delivery and translational repression of
certain mRNAs in dendrites (39).

FMRP associates with the RNA induced

silencing complex and miRNAs (40). FMRP plays a role in growth cone collapse
through translational suppression of microtubule associated proteins (41).
An RNA sequence known as cytoplasmic polyadenylation elelment (CPE)
is found in the 3’UTR of some transcripts, and is recognized by the protein CPE
binding protein (CPEB). This protein regulates the expression mRNAs through
cytoplasmic polyadenylation and localization (42). CPEB binds specific
sequences to repress translation, but elongates the poly-A tail in response to
signaling events to promote translation (43).
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Iron response protein (IRP) functions to regulate the expression of genes
containing the iron response element (IRE) such as ferritin (44), erythroid 5aminolevulinate synthase (45), mitochondrial aconitase (46), and succinate
dehydrogenase-iron protein (47) in order to control iron homeostasis (44). The
IRE is close to the 5’ cap in these mRNA and the binding of the initiation complex
is prevented when IRP is bound (48).

Cap-Independent Translation
The internal ribosome entry site (IRES) was first discovered in
picornaviruses (49). The pseudoknot structure of the RNA is essential for IRES
function (50). Picornaviral IRESes show binding for eIF3 and eIF4G (51). The
IRESes from hepatitis C and swine fever viruses bind the 40S ribosomal subunit
without the need for any of the initiation factors (52). Other IRESes interact with
proteins that are not the typical translation initiation factors, but may facilitate
recruitment of the ribosome. These non-canonical initiation factors include
heterogeneous nuclear ribonucleoproteins, a polypyrimidine-tract-binding protein
that is a regulator of splicing (53), La, an autoantigen involved in RNA
metabolism (54), death associate protein (DAP5), an eIF4G analog (55). DAP5 is
homologous to the C-terminal two thirds of eIF4G and is capable of suppressing
both cap-dependent and IRES mediated translation (56). Different viral classes
may require different factors to mediate translation (49).
The IRES can control translation of a downstream open reading frame
(ORF) of a bicistronic mRNA without affecting the translation of the upstream
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ORF, Figure 1.3 (57). Translation at an IRES still occurs even when capdependent translation is impaired (58). During picornaviral infection a protease
cleaves eIF4G in half and cap-dependent translation is shut down in the host.
This allows the virus to focus the translation machinery upon its RNAs using the
C-terminal half of eIF4G for IRES mediated translation (59).
Encephalomyocarditis virus and poliovirus prevent the phosphorylation of 4EBP1, which represses cap-dependent translation, but which has no effect upon
IRES related translation.

Figure 1.3. Cap-independent translation does not require the RNA binding proteins, eIF4E and
PABP, of the initiation complex. Some of the other initiation factors may be necessary to recruit
the ribosome.

Cells used cap-independent translation during periods when cap-dependent

translation is silenced.
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Functional cellular IRES’s have been found in yeast, Drosophila, birds and
mammals. IRES dependent translation is a regulatory method that cells use to
cope with stress. Cellular IRES elements are found to be active even when capdependent translation is silenced during mitosis, quiescence, differentiation, and
stress such as γ-irradiation (54), hypoxia (60) and amino acid starvation (61).
Cap-independent translation can be regulated by its own factors for
control of expression completely independent from cap-dependent translation
levels. The controlled activity of these factors is capable of regulating the time
and place of translation, and has been shown to temporally control translation
during certain periods of the cell cycle.
Cap-independent translation may even play a role in spatially controlling
the translation of certain mRNAs.

Proteins that make up the cap-binding

complex are present in low concentrations in dendrites compared to the soma.
Five neuronal mRNAs are found to be translated in dendrites through IRES
dependent initiation (62).

Dysregulation of Translation in Disease

The proper expression of proteins is essential for normal cellular function.
Uncontrolled production of certain genes is the cause for many disease states.
Lots of attention has been focused on the transcription level expression of genes
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and how it affects disease states.

Excessive or insufficient translation in a

certain region of the cell can contribute to disease states.
Mutation in FMRP causes fragile X syndrome, which is the most common
genetic cause of intellectual disability and autism (63). FMRP is expressed only
in the brain and is found with ribosomes or in RNPs and in dendritic spines, but
small amounts are also present in the nucleus (64). Absence of this protein
leads to over expression of FMRP associated mRNAs in dendrites.
In neurons, synaptic stimulation induces protein synthesis (65). Disruption
of protein synthesis impairs long-term potentiation (66). mTOR regulates capdependent translation during LTP and memory consolidation (67). Dysregulation
of the mTOR pathway is implicated in the mechanisms of neurological disorders
including autism and epilepsy (68).

Conclusion
A cell’s ability to control translation in a sub-cellular manner allows it to
produce proteins in a spatially controlled manner.

This process is highly

regulated and functions to keep the cell healthy, and is important for many
developmental processes. Spatially controlled translation is especially important
in neuronal cells for guidance of neurites and synaptic activity. Problems with the
regulation of sub-cellular translation are implicated in many diseases. Therefore
more tools to study the translation of a specific gene are needed to study the
importance and mechanism of these processes.

13

1.2 Optogenetic Control of Biological Events

Introduction
The field of optogenetics has shown how much can be learned from new
tools to manipulate cellular behavior.

Optogenetics is a broad field

encompassing many techniques that employ optics and genetics in combination.
This applies to light responsive proteins as well as other biological systems
engineered to respond to light. Optical control lends investigators the ability to
precisely deliver activation from light in time and space.

By combining the

genetic control of the system’s protein expression and a light activation, the
method has the ability to control the responses spatially, temporally, and
biologically.
Optogenetics addresses the need to control defined events in defined cell
types at defined times in intact animal systems.

Because of this the use of

optogenetic tools has shown great promise as a tool for very specific activation.
Much has been learned from the sub-cellular application of optogenetics in
neurons.

What is learned from optogenetic systems in general show the

versatility and adaptability of optogenetics as a tool.
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Optogenetics of Rhodopsins

One of the most influential tools developed in optogenetics uses light
activated ion channels to manipulate the synaptic activity of neurons. The ion
channels were originally discovered in bacteria where there are a large variety of
species that use photo responsive proteins (69). These proteins use retinal as
cofactor to respond to light and thus they are collectively called rhodopsins. The
most popularly used rhodopsin is channelrhodopsin (ChR), one that allows the
passive transport of cations from irradiation with blue light (70), which has been
used in neurons to depolarize the cell membrane.

Control from Optogenetics

Optogenetics has achieved specificity for a target in several ways
including, targeting certain cell types based upon expression of a specific
promoter, by spatially restricted delivery of virus to target a specific neural
structures, and by precisely controlling the delivery of light to activate the system
(71).
Viral infection has been used with many optogenetic tools because it is an
efficient way to deliver gene components into living animals.

The area of

injection can control the general organ or substructure of an organ that is
infected, Figure 1.4. In addition, it is possible to illuminate an axon far from the
cell body where the opsin was introduced because the opsins are trafficked down
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the axon, Figure 1.5. This provides the ability to control the projections of cells to
select the cells of interest without any genetic knowledge of the cell (72).

Figure 1.4. Different regions of the brain can be targeted for delivery because of the spatial
separation of the anatomical structures.

An optogenetic construct can be virally delivered such

that the infection is localized near the region of delivery. This allows the expression of this gene
only in the specific area of delivery.

Figure 1.5. Light activation of optogenetics allows sub-cellular control through optical precision.
The axons of neurons may extend across the brain such that the process and the cell body are
well separated in space.

Studies in intact brains can illuminate neuron projections to target

protein activity on a subcellular level. This allows specific spatial control over the activation of
optogenetic proteins.
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Because they employ a genetic component, these tools can be controlled
by the genetic context they are given. Therefore cell type specific promoters can
control the expression of the system. In this way the CamKII expressing neurons
have been targeted to selectively express genetic components, Figure 1.6A. The
use of specific promoters can be somewhat difficult when using viruses because
the payload is usually less than 4kb, while strong and specific promoters may
often be too large for this.

Figure 1.6. (A) Using a cell type specific promoter can control expression of optogenetic tools. A
specific subset of cells in the hippocampus express the CamKII promoter. Only these cells will
express an optogenetic protein, ChR2, fused to a red fluorescent protein, dTomato. The Cornu
Ammonis areas CA1 and CA3 show some expression of this promoter, while the dentate gyrus
(DG), shows strong expression of the CamKII promoter. (B) Transgenic mouse lines expressing
recombinase enzymes under a specific promoter can be used in conjunction with recombinase
dependent optogenetic expression. This allows the use of a small and strong promoter when
infecting the optogenetic component, ChR2 fused to YFP. The optogenetic protein will only be
expressed in cells where the recombinase is present.
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This issue has been somewhat mediated by using transgenic animals that
express the recombinase Cre under specific promoters. The restricted presence
of the recombinase causes the restricted expression of recombinase dependent
constructs, Figure 1.6B. In this way the field of optogenetics can be combined
with the plethora of transgenic recombinase expressing animals.
Channelrhodopsin was first used to depolarize hippocampal neurons to
induce synaptic events (73). Later optogenetic control was feasible even in intact
mammalian brain tissue (74) and freely moving mammals (75).

This allows

researchers to learn about the roles of cells by how they transform the given
input information that we give them and how that transformation changes based
upon biological conditions.
Optogenetics has been used to study how different cell types contribute to
the function of certain pathways and interactions. There have been studies into
mechanisms of deep-brain stimulation for Parkinson’s disease (76) and the role
of nucleus accumbens in modulating cocaine reward (77). It has been used to
study the contribution of hypothalamic hypocretin neurons to sleep and
wakefulness (75), to examine dopamine-modulated addiction (78), to do
functional mapping of the motor cortex (79), and to investigate the amygdala
neurons in regulating anxiety (80). The most important impact of optogenetics is
from use as a research tool to obtain insights into complex tissue function.
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Photo Inducible Dimerization

Protein dimerization is a modular switch that can be inserted into
processes controlled by protein proximity. Inducible dimerization has become an
increasingly popular tool for controlling biological processes because of its
versatility.

Engineered dimerization has allowed the investigation of many

processes because it is adaptable to any situation that can be controlled by the
proximity of two proteins such as signaling network interaction or protein complex
formation.
Chemically induced dimerization has already been shown to activate
transcription, reconstitute a functional protein from separated domains, and
control protein translocation to cellular organelles. Photo induced dimerization is
based upon photo activation of chemical changes that induce protein binding and
should be able to do anything that has been controlled with chemically inducible
dimerization, but additionally provides greater spatial and temporal control.
Controlling dimerization is more generally applicable than pharmacological
and photochemical tools because it can be adapted to diverse biological
situations and has specifically controlled interactions that have less off-target
effects. Other kinds of light regulated proteins (channelrhodopsin) or caged
compounds (glutamate) have specific purposes and may not be good for
engineering biological outcomes based upon protein proximity, but have shown
the benefits of using light to control activity.

19

There are two ways in which researchers have developed photocontrolled
dimerization of proteins. In one scenario the light-sensing molecule is unbound
but can interact with the protein; in the other the light-sensing molecule is integral
to the protein. Of the first variety there are many ligands that induce dimerization
but just a few that have been caged by light cleavable moieties, making a light
dependent dimerization system. Of the second variety there are a number of
light activated dimerizing pairs that have been taken from their natural functions
and put to new uses.

Photocaging Chemical Dimerizers

Photo cages allow spatially and temporally resolved manipulation through
controlled delivery of light. Many biologically relevant small molecules have been
photo caged. Caged calcium chelators were used to observe the effects from
calcium concentrations on muscle contraction, neurotransmitter release and ionchannel gating (81). Caged glutamate was used to explore the function of AMPA
and NMDA receptor and in long term potentiation in synapses, and could be
used to activate individual dendritic spines (82). Caged ATP was the first caged
molecule used in biology (83) and has since been used to study
sodium/potassium pumps (84). There has been use of caged nucleic acids to
temporally control gene expression (85).
A photo cage must be removable by light and yet must also be stable
enough to not be cleaved under biological conditions.
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It also has to block

biological activity of the caged molecule (e.g. inducing protein dimerization). The
photocages need to be cleavable by common wavelengths used in fluorescence
microscopy. Other characteristics that make a good cage are good solubility in
aqueous solution, long wavelength absorption and high absorption coefficient.

Figure 1.7. Nitrobenzene derivatives are the most commonly used photo caging groups. They
can be conjugated to many types of functional groups such as carboxylic acids, phosphates,
hydroxyls, and amines.

These groups can be cleaved with light to produce the free caged

molecule and a nitrosobenzene product.

The most commonly used photo cage is nitrobenzene and its derivatives,
Figure 1.7. This group of photo cages is cleaved by light from 260nm to 350nm
depending upon the structure of the cage and the ligand (86). These can be
attached to a variety of different functional groups, Figure 1.7.

There are other

classes of photo cages including p-hydroxyphenacyl and coumarin.
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The

coumarin compounds have the advantage that they can be cleaved with longer
wavelength light, 320nm to 400nm (86).
Photocaging of chemical inducers of dimerization takes a small molecule
dependent protein-binding event and puts it under the control of light. The small
molecule is covalently linked to a large molecule in such a way as to block its
ability to interact with the protein pair and therefore cage it in the dark state,
Figure 1.8. Upon irradiation these photocaging groups access a high-energy
state that facilitates the breaking of the linkage to the small molecule allowing it
to interact with its protein pair and induce dimerization.

Figure 1.8. Chemical dimerizing systems use a small molecule to induce the binding of two
proteins. Several chemical dimerization systems have been engineered to be light responsive
including rapamycin (A) and gibberellin (B) dependent dimerization. The ligands, rapamycin and
gibberellin, have been caged to block the interaction with the dimerizing protein pair. Irradiation
of the cage causes release of the small molecule, which can then induce dimerization.
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Rapamycin
Rapamycin is the most widely used chemical inducer of dimerization in
engineered systems. Rapamycin is a macrolide bacterial natural product that
binds the FK506 binding protein 12 (FKBP12) and this complex binds an FKBPrapamycin binding (FRB) domain, Figure 1.8 (87). There are endogenous FRBs
and FKBPs present in mammalian cells that are affected by rapamycin. A well
known protein that is involved in the regulation of translation is named the
mammalian target of rapamycin (mTOR) and contains an FRB domain.
Rapamycin inhibits translation of proteins from binding mTOR and endogenous
FKBPs and has immunosuppressive and anti-proliferative effects.
The hydroxyl group at C-40 was caged to prevent intermolecular contacts
to FKBP12. The simple caging of rapamycin does not reduce the affinity enough
to prevent binding to FKBP12 and FRB. Both the caged and free rapamycin
induced dimerization with wild type FKBP12 with or without UV. Hence there is
sufficient dimerization of the proteins that there is no “off” state in the dark.
Several strategies were used to circumvent the difficulty in caging rapamycin.
It was thought that the complex was not sensitive enough to be perturbed
by the caging. A mutant form of FKBP12 termed iFKBP, was used because it
has increased flexibility in the loop that is next to C-40 of rapamycin, Figure 1.9.
Caged rapamycin binds to iFKBP and distorts the proteins conformation in order
to make extra contacts with the molecule, and is not able to bind FRB. Irradiation
with 365nm light was able to release rapamycin and induce dimerization (88).
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Figure 1.9. Rapamycin was caged at C-40 with a nitrobenzene derived photoprotecting group.
The cage did not prevent dimerization of wildtype FKBP and FRB in the dark. FKBP was mutated
so that dimerization did not occur when rapamycin was caged, but did occur once the cage was
released.

Another group attached biotin to the photo cage and incubated it with
streptavidin, Figure 1.10.

This structure was unable to permeate cell

membranes, but once cleaved the free rapamycin was able to cross and interact
with its protein pair (89). This strategy works best when the target is at or near
the membrane, and for short periods of time because of diffusion.
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Figure 1.10. Rapamycin was caged at C-40 with a nitrobenzene derivative. The nitrobenzene
was linked to biotin and incubated with streptavidin. The presence of the large moiety prevented
the molecule from crossing the membrane, essentially sequestering it. This prevented the
interaction of rapamycin with FKBP or FRB in the cell until the cage was cleaved, and then free
rapamycin was able to enter the cell.

In addition, a rapamycin dimer was created with a photo cleavable linker in
between. This dimer was capable of homodimerization of FKBP12, but could
induce heterodimerization between FKBP12 and FRB once cleaved (90).

Gibberellin
Gibberellic acid (GA3) is a pentacyclic diterpene that promotes growth and
elongation of plant cells. GA3 binds to a receptor protein gibberellin insensitive
dwarf 1 (GID1) in plants causing a conformational change in the protein so as to
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be able to bind the protein gibberellin insensitive (GAI). GID1 has a tight binding
pocket for GA3, which makes it easy to install a molecular cage for GA3. GA3
itself is not membrane permeable, but esterified versions of it are (91). The
cages allow the molecule to cross the membrane and once cleaved free GA3 is
unable to leave the cell.

Figure 1.11. Giberellin was caged with nitrobenzene derivatives. Substitution of nitrobenzene
derivatives is capable of tuning the physical properties of the compound.

Methoxy groups

increase solubility in aqueous solutions and enable cleavage with slightly longer wavelengths for
the DMPP caged compound pcGA3-1. The addition of phenyl groups an extended pi networks in
EANBP and π-extended NPP gives better two-photon absorption and uncaging for the pcGA3-2
and pcGA3-3.

GA3 was caged with 2-(4,5-dimethoxy-2-nitrophe- nyl)propyl (DMNPP), 2(4’-bis((2-methoxyethoxy)ethyl)amino)-4-nitro-[1,1’-biphenyl]-3-yl)propan-1-ol
(EANBP), and 2-(o-nitro-phenyl)propyl to allow one and two photon uncaging,
Figure 1.11. The cages were stable against cellular esterases and could be
cleaved with either 412nm light for one photon uncaging or 800nm light for two
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photon uncaging. The caged molecule only needs to be irradiated for seconds to
be released (92).

Light Responsive Proteins

Photosensitive proteins bind molecular cofactors that can undergo
isomerization or formation of bonds upon absorption of a photon; the
rearrangement of the cofactor is felt by the protein and propagated to the rest of
its structure. These proteins are used in nature to initiate signaling cascades to
allow organisms to detect and react to light. The light signaling pathways have
been used with phytochromes, and flavin proteins, Figure 1.12.
Photodimerizing proteins have been used to control biological activity in a
similar manner as chemically induced dimerization. The small molecule that
responds to light is integral to the protein, therefore the activity is mediated by the
presence of the photoactivated protein. A large protein will diffuse more slowly
than a small molecule and therefore there have been several photodimerizing
systems used to control activity on the sub-cellular level.
In addition to the advantage of increased sub-cellular control, there are
some drawbacks to using photodimerizing proteins. Researchers have aimed to
use longer wavelength activation in cells to minimize photo toxicity. Because of
the specificity of the protein for its chromophore, the molecule cannot be altered
and therefore its properties cannot be easily tuned in the way a photocage can.
The chromophores of some systems may not be bioavailable from the host cell
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and must be added in some cases (93). Some proteins will homo-oligomerize
with themselves instead of hetero-dimerizing with their partners complicating the
outcomes of biological investigations (194).

Figure 1.12.

Photodimerizing systems have been borrowed from nature and engineered as

optical switches. (A) The light-oxygen-voltage domain is found in natural proteins, such as FKF1.
This domain unravels a helix in response to light, which exposes a binding site for the protein GI.
(B) The LOV domain was fused to a peptide tag (red) such that the tag is unable to bind its
cognate protein, PDZ, in the dark. Upon irradiation the helix containing the tag unfolds and is
able to bind PDZ.

(C) Upon absorption of red light phytochrome proteins, PHY, undergo a

conformational change that creates a binding site for the protein PIF. The PHY protein will also
absorb far-red light to revert back to the non-dimerizing state. (D) Cryptochrome proteins, CRY,
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absorb blue light, which results in a conformational change that allows the binding of the protein
CIB.

LOV DOMAIN
Proteins containing the light-oxygen-voltage (LOV) domains are found in
plants and bacteria and are found to have many diverse roles in signaling. In the
LOV domain the specific cofactor is a flavin mononucleotide (FMN).

Upon

absorption of blue light the FMN forms a covalent bond between the C(4a) and a
cysteine in the LOV domain, Figure 1.13 (95).

The formation of the bond

propagates a conformational change to the LOV domain. This change causes
unfolding of the C terminal helix, Jα, which confers the signal to the effector
domain.

Figure 1.13. FMN forms a bond with the sulfur of cysteine from the LOV domain upon absorption
of blue light photons. Spontaneous reversion from cleavage of the cysteine adduct occurs in the
dark.

FKF1 GIGANTEA
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The flavin binding kelch repeat F-box 1 (FKF1) protein uses a LOV
domain to sense light in Arbadopsis thaliana. Upon irradiation the conformational
changes in the LOV domain of FKF1 expose a binding site for the protein
gigantean (GI). Proteins had visibly dimerized five minutes after irradiation and
stayed associated for one and a half hours. Spontaneous reversion occurs with
the hydrolysis of the FKF1-FMN bond and the disassociation of the proteins.
This system requires up to 30 minutes for maximum effect and has slow
spontaneous reversal kinetics (96).
The proteins showed noticeable levels of dimerization in the dark,
especially when both were expressed in high levels.

Mutations improved

background dimerization in the dark by destabilizing the protein-protein interface.
The mutation showed no decrease of the ability of the protein pair to associate
through photoactivation. Additionally, even though the LOV domain is only 125
amino acids the full length FKF1 is 1,173 amino acids and may be difficult to use
in some scenarios because of its size.

LOV PDZ
In the dark state a peptide tag fused to the end of the Jα is sterically
blocked by the folded structure. Upon irradiation the Jα helix undocks from the
core and unfolds. The unfolding of Jα allows the tag to be exposed and able to
bind a protein a protein named PDZ. This results in light inducible dimerization of
LOV domain and the PDZ protein (97).
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PDZ domains are used to organize protein complexes. They bind to a
short peptide sequence on the C terminus of a specific protein. Because PDZ is
naturally occurring, there could be cross talk with endogenous signaling
pathways.

Phytochromes
Phytochrome (PHY) proteins are used by plants, bacteria and fungi to
regulate growth and development in response to light (98).

Phytochrome is

covalently bound to the tetrapyrrole chromophore bilin via the N-terminal region
(98). Absorption of a red photon causes the E/Z isomerization from Pr to Pfr form
of the molecule, Figure 1.14. Irradiation with far-red light causes another
isomerization of the chromophore back to the Pr state.

This molecular

movement to the Pfr state translates into a physical change in PHY such that it
binds to the protein PIF.
The two states, Pr and Pfr, are both relatively stable and so the
dimerization can be turned off by light as well, and the switching is found to be
indefinitely repeatable (99). A subcellular area was activated by red light while
the area around it could be inactivated by far-red light, thus confining the area of
activity (99).

In this way they were able to control protein dimerization on the

order of micrometers.
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Figure 1.14. The Pr state of the billin chromophore in PHY isomerizes in response to red light to
form the Pfr state. The Pfr state isomerizes back to the Pr state from absorption of far-red
photons.

Unfortunately the chromophore is not endogenously expressed in
mammalian cells and a precursor phycocyanobilin (PCB) must be incubated with
cells for some time before the experiment for optimal excitation (93). It was
shown to require a 30 min incubation with 5uM PCB for the molecule to be
incorporated into the PHY protein (99).

Cryptochromes
Cryptochromes (CRY) are photoreceptors found in animals, plants,
bacteria and fungi. These proteins sense light through a flavin adenine
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dinucleotide (FAD) chromophore that changes oxidation state in response to
absorption of blue light, Figure 1.15. The changes in FAD lead to conformational
changes in CRY, which is then able to bind the protein CIB. Excitation with blue
light gives dimerization within seconds and dissociation in ten minutes (94). This
system can also be activated by 820-980nm light with two-photon excitation.

Figure 1.15. The mechanism of FAD signaling in cryptochromes is not completely resolved.
Upon absorption of blue light the chromophore becomes reduced, but the exact species formed is
still unclear.

Photoactivation of Biological Events
Photoinducible dimerization may be applicable to any biological event that
can be controlled by protein proximity, but so far has only been applied to a
select few events.

Targeting proteins to specific subcellular locations based

upon a protein anchor is a common feature in dimerization-based techniques.
An anchored protein has been used to target the bud neck, nucleus, myosin ring
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of bud, endosome, nucleolus, peroxisomes, spindle pole body and plasma
membrane in yeast (100). Other protein anchors have been used to localize
proteins to the mitochondria, centrosome, and kinetochores in mammalian cells
(101). Targeting of active proteins to different sub-cellular compartments has
been used to control their interactions with effector proteins (100). Commonly
targeted areas are specific DNA sequences to control gene expression and the
plasma membrane to control signaling cascades.

Targeting Functional Proteins to DNA Sequences
Localizing the transcription machinery to a specific gene is a common
application of dimerizing proteins. It can be used to control the expression of
reporter genes, such as luciferase and GFP, or functional genes. A DNA binding
domain is fused to one of the dimerizing proteins to target a specific sequence
and therefore a specific gene.

The other dimerizing protein is fused to any

protein that modulates expression of a gene, such as transcription activator,
histone modifier, or recombinase. Activation with light causes the effector protein
to be present at the gene’s locus upon dimerization.
There is a large variety of DNA binding proteins available for use in
targeting a specific gene. The Gal4 DNA Binding Domain (GAL4BD) has often
been used to localize one protein partner to the GAL upstream activating
sequence. A zinc finger protein (ZFP) can be used to target a specific sequence
(102). The DNA binding domain from the transcription activator-like effector
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(TALE) protein has a repetitive structure and can be tailored to match many DNA
sequences to target a specific gene locus.
Dimerization dependent transcription can be engineered by controlling the
interaction of the transcription machinery and a specific gene. VP16 activating
domain has been widely used to recruit transcription machinery to a specific
gene (102-103). Genes can be transcriptionally silenced from the targeting of a
transcriptional repressor and deacetylase (103). Cre recombinase can also be
targeted to a specific DNA locus to activate recombinase dependent genes (94,
104)

Inner Membrane Localization
Several systems have used photoinduced dimerization to bring a protein
to the membrane to stimulate a cell-signaling cascade. Translocation of active
enzymes to the membrane to control cell protrusion is a common application to
visualize subcellular spatial control, Figure 1.16.
The C-terminal farnesylation motif from K-Ras called the CAAX box is
commonly used for membrane targeting (96). The N-terminus of Lyn is also
commonly used to target the membrane (97). The myristoylation sequence at the
N-terminus of SOS has been used for membrane recruitment.
The MAPK pathway has been investigated through the membrane
localization of the scaffold protein Ste5, the GTP exchange factor SOS, the
GTPase Ras and the signaling kinase Raf in different experiments. This MAPK
pathway regulates proliferation, differentiation, survival, and apoptosis.
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Another pathway that has commonly been targeted is the phophoinositide
3 kinase (PI3K) pathway. This pathway works through the effector proteins AKT,
and protein kinase C to control growth, survival, migration, and cell cycle
progression. 5-phosphatase was localized to the membrane to control temporally
control phosphoinositide metabolism (105).

Figure 1.16. Many photodimerizing pairs have been used to control the subcellular activation of
signaling cascades. (A) PHY/PIF was used to target Tiam1 to the membrane to activate Rac1
dependent signaling.

(B)

CRY/CBI was used to target 5-phosphatase to activate

phosphoinositide dependent signaling. (C) LOV/PDZ was used to target Cdc24 to the membrane
to activate signaling. (106)
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Another common pathway employed is the Rho GTPase family to regulate
actin dynamics. Often the GTP exchange factors such as Tiam1, intersectin, and
Tim are targeted to the membrane to stimulate Rac1, RhoA, or Cdc42 (99). The
GTPases Rac1 and Cdc42 have also been targeted to the membrane (97).

Conclusion
Optogenetic control is capable of precise manipulation of neural circuitry in
living brains. The technique demonstrates the advantages of using genetics and
viral delivery to limit expression to certain cell types in combination with
photoactivation.

Sub-cellular stimuli can be delivered and responses give

information about connectivity and function.
Photoinducible dimerization is one of the optogenetic techniques that can
be adapted to control many biological events. This technique can be controlled
on the sub-cellular level to spatially sensitive biological events. This technique
may be suitable for using as a switch to control sub-cellular activation of protein
translation.

Photoinducible dimerization may be able to bring the translation

machinery into proximity to a specific RNA sequence in a light dependent
manner.

This may be able to be a tool for investigating the sub-cellular

translation of proteins and their roles in development, growth, and functions of
cells.
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Chapter 2 – Photoactivation of Dimerization

2.1 Introduction
One of the goals of my research is to develop a photocaged chemical
dimerizer to mediate light-controlled protein dimerization.

For this I will use

abscisic acid (ABA) dependent dimerization of the proteins pyrabactin-like
regulatory component (PYL) and ABA insensitive (ABI). Based on the crystal
structures (1), ABA is completely encapsulated by PYL, Figure 2.1, so any
disruption of the three dimensional shape of ABA should prevent binding.

Figure 2.1. ABA is bound by PYL such that it completely encapsulated by the protein. There are
many contacts between the carboxylic acid of ABA with residues of PYL. Disruption of these
contacts through caging should be able to block ABA binding and therefore dimerization. (1)
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The encapsulation of ABA by PYL suggests that any chemical
modification to ABA should act as a cage to prevent dimerization of PYL and ABI.
The carboxylic acid of the molecule was the easiest functional group to target for
caging chemistry. Therefore the design for photo inducible dimerization uses
photocaged ABA through attachment at the carboxylic acid to block dimerization
in the dark. Photorelease of ABA should be able to induce dimerization of PYL
and ABI to provide a light dependent switch for protein proximity, Figure 2.2.

Figure 2.2. Design for photoinducible dimerization of PYL and ABI from release of ABA.
Attachment of a photocage on the carboxylic acid of ABA should prevent binding to PYL. Upon
irradiation the caged should be released and ABA would be able to bind PYL inducing
dimerization with ABI.

To test whether the photocaged version of ABA can be developed by
modifying its carboxylic acid group, I decided to cage ABA with commonly used
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photocaging groups. o-Nitrobenzene groups are one of the most widely used
photocaging groups. They can be attached to many functional groups such as
alcohols, phenols, carboxylic acids, and phosphates and have been successfully
uncaged (2). The photochemical reaction is an intramolecular H-abstraction by
the excited nitro group, which then forms an aci-nitro and rearranges into the
nitroso derivative, Figure 2.3 (3). Most of the nitrobenzene-derived groups have
a maximum absorption below 300nm, which may give low uncaging efficiency
with biocompatible wavelengths. A 3,5-dimethoxy substituted nitrobenzene
(DMNB) has a longer wavelength of absorption and can be cleaved with 365nm
light (1). DMNB caged glutamate shows maximum absorption at 345nm (4).

Figure 2.3.

Mechanism of nitrobenzene photocleavage.

Absorption of a photon causes the

rearrangement of the nitro group to form the aci-nitro group.

This undergoes further

rearrangement to release the protonated small molecule (HX) and the nitrosobenzene product.

Coumarin-4-ylmethyl groups and its derivatives have a slightly longer
wavelength, 320nm to 400nm (2), of cleavage than the nitrobenzene. Coumarin
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cages can be linked to carboxylic acids and phosphates through ester bonds,
and also linked to amines and alcohols.

Photoexcitation of the coumarin

molecule causes the heterolysis of the C-O bond to form an ion pair, Figure 2.4
(5). Once the ion pair is separated it is trapped in a polar solvent to give the
hydroxyl coumarin and the protonated molecule. Substitution on the 6 and 7
positions of the coumarin ring have been found to enhance the solubility and
increase the efficiency of photorelease.

Figure 2.4. Mechanism of coumarin photocleavage. Absorption of a photon causes the cleavage
of the bond to the caged molecule (X) creating an ion pair. In solvent this ion pair is converted to
an coumarin alcohol and the protonated small molecule (HX).

I want to photocage the small molecule ABA to prevent its ability induce
the dimerization in the dark, and be able to activate dimerization with light. To do
this I will create photocaged ABA molecules. I want to use photorelease of ABA
to induce biological effects that have shown to be controlled by other
photodimerizing systems such as transcription, protein translocation, and signal
transduction. In addition I wanted to see if the system is capable of spatially
controlled activation of signaling, as has been seen with other photodimerizing
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systems.

If spatial control can be achieved for activation of signaling it is

possible that it could be applied to the spatial control of translation as well.
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2.2 Results
Photocleavage of Caged ABA
ABA-DMNB and ABA-DEACM were synthesized by conjugating the
protecting groups to the carboxylic acid of ABA, Figure 2.5.

Figure 2.5. ABA is caged with DMNB and DEACM groups to create photoreleased ABA. The
reagent 1,8-diazabicyclo[5.4.0]undec-7-ene (DBU) was used to catalyze the reactions in
dichloromethane (DCM). DMNB caged ABA should be cleavable with 365nm light, while DEACM
caged ABA should be cleavable with 405nm light.

Testing chemical stability of caged ABA: ABA-DMNB and ABADEACM at 100µM were incubated in HEPES buffer at 37°C for 24 hours and
subsequently analyzed by HPLC. These samples were compared to solutions
that had not been incubated for 24 hours. There was a small ABA peak found in
the sample of ABA-DEACM that had not been incubated for 24 hours, Figure 2.6.
This peak may be due to contamination from the reaction starting material or it
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could be a result of spontaneous degradation of the compound. The ABA peak
was not seen to increase for either ABA-DEACM or ABA-DMNB after 24 hours.

Figure 2.6. HPLC analysis of ABA-DMNB and ABA-DEACM incubated in HEPES buffer for 24
hours at 37°C compared to samples in buffer solution not incubated for 24 hours. There was a
small amount of free ABA present in the sample of ABA-DEACM before incubation for 24 hours.
The amount of free ABA present did not increase for either compounds after incubation in HEPES
buffer for 24 hours at 37°C.

Testing photouncaging of ABA: Solutions of ABA-DMNB and ABADEACM were irradiated with either 365nm or 405nm light. The solutions were
then analyzed with HPLC and found to have an increased amount of free ABA
compared to solutions that were kept in the dark, Figure 2.7. Not only was the 2cis ABA produced as expected, but a 2-trans isomer was produced and was
more abundant than the 2-cis isomer. The reaction from photocleavage of ABA-
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DMNB showed more production of the trans isomer than the photocleavage of
ABA-DEACM.

Figure 2.7. HPLC analysis of the products of photocleavage showed a mixture of isomers of ABA.
Solutions of ABA-DMNB and ABA-DEACM at a concentration of 100µM were irradiated with
365nm light and 405nm light respectively. The photocleavage products showed the regeneration
of free 2-cis ABA, but in addition produced 2-trans ABA. The photocleavage reactions from ABADMNB and ABA-DEACM showed different ratios of the cis and trans isomers produced.

Photocleavage was quantified by integration of the HPLC peaks to give
the percentage of caged ABA compared to free ABA in solution, Figure 2.8.
ABA-DMNB could be nearly completely cleaved by irradiation for three minutes
with 365nm light at the tested concentration, while the same irradiation conditions
uncaged only 25% of the ABA-DEACM at the tested concentration.
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ABA-

DEACM was irradiated for six minutes with 405nm light and was nearly
completely cleaved. ABA-DMNB that was irradiated with 405nm light produced a
substantial amount of free ABA.

Figure 2.8.

Photocleavage of ABA-DMNB and ABA-DEACM with 365nm and 405nm light.

Irradiation of the caged ABA with 365nm light preferentially cleaved ABA-DMNB, but also resulted
in some cleavage of ABA-DECM as well (left). Irradiation of the molecules with 405nm light
resulted in slightly greater cleavage of ABA-DEACM, but still showed significant cleavage of ABADMNB.

The photouncaging of ABA-DMNB is more efficient than that of ABADEACM when using 365nm light. ABA-DMNB was nearly completely uncaged
by irradiation with 365nm light within 3 minutes, but ABA-DEACM was uncaged
just over twenty percent.

Using 405nm light uncaged over half the starting

material of both ABA-DMNB and ABA-EACM within 6 minutes.
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Testing isomerization of ABA: Free ABA was irradiated with different
wavelengths of light for 4 minutes to see how much isomerization occurs from
light, but without the photocleavage reaction. Formation of trans ABA was seen
from irradiation with UV light, but at much lower levels than those seen when
irradiating caged ABA under the same conditions, Figure 2.9. Isomerization was
not seen when ABA was irradiated with blue or green light.

Figure 2.9. ABA samples at 100µM were irradiated with different wavelengths of light for 4
minute. The samples were analyzed with HPLC to see which wavelength of light are able to
induce isomerization of ABA. Samples were irradiated for 4 minutes with each channel of the
fluorescent microscope. For UV light the DAPI filter was used that emits 365nm light; for blue
light the GFP filter was used that emits 455nm to 495nm light and for green light the Rhodamine
filter was used that emits 534nm to 558nm. Only irradiation with UV light was able to isomerize
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2-cis ABA to create 2-trans ABA, and in much lower amounts seen compared to the
photocleavage reactions of ABA-DMNB and ABA-DEACM.

Photoinducible Transcription
An ABA-inducible transcription assay was used to analyze the
photorelease of ABA in cells. Cells expressing VP16-PYL and GAL4BD-ABI were
used to activate the transcription of reporter genes, luciferase or GFP,
downstream of the GAL4 upstream activating sequence in response to ABA,
Figure 2.10.

Figure 2.10. Initiation of transcription due to chemically induced dimerization. VP16 transcription
activating domain is fused to PYL and ABI is fused to the Gal4 DNA binding domain (DBD). ABA
induced dimerization causes the localization of VP16 to the Gal4 upstream activating sequence
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that binds GAL4DBD.

This recruits the transcription initiation complex to a reporter gene

downstream from this sequence.

The 2-cis form of ABA is shown to stimulate transcription of reporter genes
(6), but trans ABA has been shown to have decreased biological activity (7). I
wanted to test the abilities of the two different isomers to induce dimerization
dependent transcription because they are both produced in the photocleavage
reaction.
Cis and trans ABA were created through the photouncaging of ABADMNB and isolated with HPLC fraction collection. The isolated compounds were
added to cells transfected with transcription inducing constructs at a
concentration of 10µM and incubated for 24 hours. The cis ABA is much more
effective for inducing transcription, Figure 2.11. When 10µM of each isomer was
added to the cell culture it gave luciferase expression greater than that seen with
only 10µM cis ABA. This indicates that even though the trans isomer is not
effective at inducing dimerization, it will not prevent the cis isomer from doing so.
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Figure 2.11.

CHO cells were transfected with constructs for ABA inducible transcription of

luciferase. Cells were given either 2-cis ABA or 2-trans ABA at a concentration of 10µM and
incubated for 24 hours. Luciferase expression was much lower in cells incubated with 2-trans
ABA compared to 2-cis ABA.

This indicates that the trans isomer is incapable of inducing

dimerization.

Testing biological stability of caged ABA: There are endogenous
esterase enzymes that exist in cells that could act to cleave the linkage between
ABA and the protecting group. Therefore caged ABA at a concentration of 10µM
was added to cells that were transfected with transcription inducing constructs to
test the stability of the caged molecule in a biological system. There was little
increase in the expression of the luciferase reporter gene even after incubation
with the caged ABA for up to 24 hours in the absence of light, Figure 2.12. This
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shows that the cages are stable in cell culture and can be used for hours in an
experimental setting with minimal amounts of transcription induction. This
indicates that the DMNB and DEACM cages are capable of preventing
dimerization in the dark state.

Figure 2.12. The stability of ABA-DMNB and ABA-DEACM in cell culture for up to 24 hours was
tested. CHO cells were transfected with constructs for ABA inducible transcription of luciferase.
Cells were incubated with ABA or caged ABA at a concentration of 10µM and kept in the dark for
either 12 or 24 hours.

Cells incubated with either ABA-DMNB (left) or ABA-DEACM (right)

showed much lower luciferase expression than that of cells incubated with ABA. This suggests
that the cages are capable of blocking the dimerization of PYL and ABI to prevent ABA induced
transcription.
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Testing photocleavage products for transcription induction: The preirradiated solution of ABA-DMNB was added to cells containing the transcription
inducing constructs with the GFP reporter. Cells showed induction of GFP from
incubation with the solution of irradiated ABA-DMNB, while ABA-DMNB that was
not irradiated did not induce GFP expression, Figure 2.13. This indicates that the
photocleavage products contain active ABA and are able to induce dimerization
dependent transcription.

Figure 2.13. ABA-DMNB at 1mM was irradiated for 3 minutes. Products of photocleavage were
diluted to 10µM and added to 293-GFP cells containing ABA inducible GFP constructs. Cells that
received ABA or photoirradiated ABA-DMNB showed increased GFP expression compared to
cells that were not given ABA or were given ABA-DMNB at 10µM that was not irradiated. Scale
bar 100µm.
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Testing photoinduced transcription: Caged ABA at a concentration of
10µM was added to cell culture transfected with luciferase inducing constructs.
The cells were irradiated with UV light to analyze the ability of photorelease of
ABA in situ. There was an increase of luciferase expression that was similar to
the increase seen from the addition of free ABA, Figure 2.14.

The level of

response of transcription activation can be controlled by the dosage of ABA or
photoreleased ABA over a wide range of concentration. This system could be
used to precisely control the amount of transcription activated by photocleavage.
In addition it indicates that the amount of dimerization can be controlled as well,
which could be used to affect the intensity of the desired biological response.
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Figure 2.14.

CHO cells were transfected with constructs for ABA inducible transcription of

luciferase. Cells were incubated with ABA or ABA-DMNB at concentrations ranging from 100nM
to 30µM. Half of the cells incubated with ABA-DMNB were irradiated with 365nm light for 2
minutes and half were kept in the dark. The cells that had been incubated with ABA-DMNB and
irradiated (red) show similar luciferase expression to the cells incubated with ABA (blue), and
greater than those incubated with ABA-DMNB and kept in the dark (black).

Photoinduced Protein Translocation
In order to be able to watch the photoinduced protein dimerization in real
time I used it to control translocation of a fluorescent protein.

I wanted to

visualize the effects of photoreleased ABA upon translocation of GFP. For this I
used a GFP-PYL construct that is not localized to any given cellular region on its
own. I used ABI that was linked to a nuclear export sequence (NES) to be able
to translocate the GFP-PYL out of the nucleus upon production of free ABA,
Figure 2.15.
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Figure 2.15. GFP-PYL dimerizes in response to ABA, which causes loss of GFP fluorescence in
the nucleus.

Testing photoinduced translocation: Cells were given caged ABA at
10µM immediately prior to experiment and either irradiated for 2 min or kept in
the dark, and were fixed after 15 minutes. Photouncaging of ABA caused an
increased amount of cells to display nuclear export of GFP compared to caged
ABA that was kept in the dark, Figure 2.16. There are slightly elevated levels of
cells showing nuclear export when they are incubated with ABA-DEACM without
UV compared to cells that were given no drug, Figure 2.16. This may be due to
small amount of fee ABA present in the ABA-DEACM sample.
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Figure 2.16. CHO cells were transfected with PYL-GFP and NES-ABI. The cells were given ABA
or ABA-DEACMat 10µM. Half of the cells containing ABA-DEACM were irradiated with 405nm
light and the other half was kept in the dark. Cells were incubated for 1 hour after treatment
before they were fixed. The number of cells showing nuclear export of GFP was counted to get
the overall percentage of the cell population showing nuclear export fo GFP. Cells that were
given ABA or ABA-DEACM and irradiated showed the highest amount of cells displaying nuclear
export of GFP. Cells that were incubated with ABA-DEACM and kept in the dark showed slightly
elevated amounts of cells displaying nuclear export compared to cells that received no drug.

Testing

reversibility

of

translocation:

The

reversibility

of

the

dimerization was analyzed by tracking the nuclear exported GFP, Figure 2.17.
Cells were transfected with NES-ABI and PYL-GFP and incubated with ABADMNB were irradiated and allowed to sit for 15 minutes like before, but next the
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media was removed and replaced with fresh media and incubated at 37°C for 5
minutes. This washing with fresh media was repeated three times before cells
were fixed. There was a decrease in the amount of cells showing nuclear export
of GFP compared to those that were not washed, Figure 2.17. This indicates
that lowering the concentration of ABA by replacing with fresh media was able to
reverse dimerization dependent protein translocation. The reversible nature of
the dimerization based upon the presence of ABA allows the system to be turned
off with the removal of ABA. This could allow more precisely controlled activation
of any dimerization dependent biological effects.

Figure 2.17. CHO cells were transfected with PYL-GFP and NES-ABI and given either ABA or
ABA-DMNB at a concentration of 10µM. Cells that were given ABA-DMNB were either kept in the
dark or irradiated with 365nm light for 2 minutes. After 15 minutes half the samples that have
been given ABA or ABA-DMNB and UV were washed three times with fresh media to remove any
ABA. The cells were then fixed and stained with DAPI for imaging (left). Scale bar 10µm. The
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amount of cells showing visible nuclear export of GFP was counted to calculate the percentages
of cells with nuclear export of GFP for each condition. Cells that were given ABA or ABA-DMNB
and UV showed increased numbers of cells showing nuclear export of GFP compared to those
with ABA-DMNB and no UV or without any drug at all.

Cells that were washed showed

decreased amounts of nuclear export of GFP. This indicates that dimerization is reversible upon
removal of free ABA.
.

Testing real-time photoinduced translocation: The movement of GFPPYL in response to photorelease of ABA can be monitored by live cell
microscopy. CHO cells transfected with NES-ABI and PYL-GFP were irradiated
with the 405nm laser of a confocal microscope and images were taken every 20
seconds for 20 minutes to track the GFP. A decrease of fluorescence intensity
was seen in the nucleus compared to the cytoplasm, Figure 2.18, of cells
incubated with ABA-DEACM and irradiated compared to those with ABA-DEACM
that were not irradiated or those that were irradiated but were not incubated with
ABA-DEACM. This indicates that the decrease in fluorescence intensity in the
nucleus is not due to photobleaching because it is dependent upon the presence
of ABA-DEACM.
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Figure 2.18. CHO cells were transfected with PYL_GFP and NES-ABI and given ABA-DEACM at
a concentration of 10µM. Cells were irradiated with the 405nm laser of a confocal microscope
and compared to cells that were not irradiated. Cells were imaged every 20 seconds to track the
translocation of PYL-GFP in real time. Cells that were irradiated showed a decrease in the
flourescence intensity of GFP in the nucleus compared to cells that were not irradiated.

The amount of translocation was quantitated using the ratio of
fluorescence intensity in the nucleus divided by the fluorescence intensity in the
cytoplasm, Figure 2.19. This showed a difference in the fluorescence intensity in
the nucleus within minutes of irradiation. This indicates that the photorelease of
ABA is able to rapidly control the translocation of a protein through dimerization
dependent anchoring of one of the ABI and PYL pair.
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Figure 2.19. The fluorescent intensity of the nucleus compared to the cytomplasm was calculated
from live cell images. Cells with 10µM ABA-DEACM showed a decrease in the relative
fluorescent intensity in the nucleus after irradiation (blue bar) compared to cells that received only
ABA-DEACM or irradiation, but not both.

Photoinduced Signaling Transduction
I wanted to see if the area of biological response could be controlled within
the region of illumination. For this we used dimerization dependent induction of
signalling cascade to visualize the rapid activation of biological events.

A

membrane targeting sequence for myrisylation was fused to ABI to give myr-ABI.
A GTP exchange factor for Rac1 activation, Tiam1, was fused to PYL-GFP. ABA
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inducible dimerization was used to target a cytoplasmic Tiam1 to the membrane
to activate a signaling cascade, Figure 2.20. The localization of Tiam1 to the
membrane results in the formation of lamelopodia and ruffles on the membrane
of the cell, Figure 2.21.

Figure 2.20. The GTP exchange factor Tiam1 is localized to the membrane upon addition of
ABA.

Tiam1 causes the activation of Rac1 signaling, which is seen by the formation of

membrane ruffling.

Figure 2.21. Cells without membrane localized PYL-GFP-Tiam1 show a smooth shape (left),
whereas cells with membrane localized PYL-GFP-Tiam1 show a ruffled phenotype (right).
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Cells expressing PYL-GFP-Tiam1 and myr-ABI that had no ABA added
still showed some cells having ruffles. Adding ABA at a concntration of 10µM to
the cell culture for one hour caused GFP localization at the membrane and
increased numbers of cells showing ruffles, Figure 2.22. Incubating the cells with
caged ABA at 10µM or no drug showed lower percentages of cells displaying
ruffles compared to cells incubated with caged ABA at 10µM and irradiated
showed levels similar to those seen with free ABA at 10µM after 24 hours.

Figure 2.22. CHO cells were transfected with PYL-GFP-Tiam1 and myr-ABI and given ABA or
caged ABA, with or with light. Cells were fixed one hour after the drug and irradiation were given.
Cells were counted to

calculate the percentage of cells showing membrane ruffles after

photocleavage of ABA-DMNB and ABA-DEACM.

The percentage of cells displaying ruffles

increases when the cells are given ABA or caged ABA and light compared to cells that did not
receive ABA or caged ABA and light. Photoreleased ABA is capable of increasing the amount of
Tiam1 signaling.
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Testing

real-time

photoinduced

signaling:

This

system

of

photoinducible signal transduction was used in conjunction with live cell
microscopy to watch the formation of ruffles in real time. Cultures transfected
with myr-AIB and PYL-GFP-Tiam1 and incubated with ABA-DEACM were
irradiated over the whole cell and showed formation of ruffles within minutes,
Figure 2.23, 2.24. Cells that were incubated with ABA-DEACM but were not
irradiated did not show formation of ruffles, Figure 2.24. The system can be used
for light dependent control over biological events.
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Figure 2.23. CHO cells were tranfected with PYL-GFP-Tiam1 and myr-ABI and either given ABADEACM at a concentration of 10µM or given no drug. Cells were irradiated with the 405nm laser
of a confocal microscope and images were taken every 20 seconds for 20 minutes. Cells that
were irradiated without ABA- DEACM did not show any changes in cytoskeletal structure. Cells
that were incubated with ABA-DEACM showed morphological changes after irradiation. Scale
bars 10µm.
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Figure 2.24. CHO cells were transfected with PYL-GFP-Tiam1 and myr-ABI and given ABADEACM at a concentration of 10µM. Images were taken every 20 seconds for 20 minutes. Cells
that were incubated with ABA-DEACM and irradiated with 405nm light showed cytoskeletal
remodeling, left.

Cells incubated with ABA-DEACM but not irradiated did not show any

cytoskeletal remodeling, right.

Testing sub-cellular induction of signaling: I wanted to test this
system’s ability to induce biological responses on the subcellular level. A small
region was selected at one end of a cell and irradiated. Subcellular irradiation did
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induce signalling transduction but this effect was not confined to the region of
irradiation, Figure 2.25.

This could be due to the rapid diffusion of free ABA to

the other regions of the cell that were not irradiated.

Figure 2.25. CHO cells were transfected with PYL-GFP-Tiam1 and myr-ABI and given ABADEACM at a concentration of 10µM. Cells were irradiated in a small region of the field (red circle)
and images were taken every 20 seconds for 20 minutes. Irradiation of a sub-cellular region did
not produce sub-cellular activation of Ruffle formation, and often caused ruffling in areas of the
cells distant from the region of irradiation (white arrow).
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It was seen in previous experiments (8) that regions of the cell that
showed cytoskeletal protrustions had more intense responses to membrane
localized Tiam1.

Therefore the diffusion of ABA throughout the cell after

photocleavage could cause the prefered activation of remodeling at these
location, independent of the location of illumination.
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2.3 Conclusion and Discussion
ABA inducible dimerization can be blocked with nitrobenzene or coumarin
derived cages linked to the carboxylic acid of ABA.

A photocleavable cage

allowed the use of light to release ABA to induce dimerization and control
designed biological effects. The system shows little dimerization when caged
ABAs are kept in the dark and high levels of dimerization after irradiation.
Photoactivation of ABA induced dimerization is capable of controlling
transcription of a reporter gene and translocation of signaling proteins.

The

system gives temporal control to signaling events that can be seen within
minutes after irradiation.

Subcellular spatial control has not been achieved,

possibly because of the rapid diffusion of ABA after irradiation.
It may be possible to achieve sub-cellular control of ABA dependent
dimerization if strategies are borrowed from other researchers. The cage could
be conjugated to a large group that could function to sequester the molecule
outside of the cell. This could allow the activation of a small area near the
membrane as it has done for others.
I have expanded the use of ABA inducible dimerization to be
photoinducible. This means that any further biological processes engineered to
be ABA dependent could be put under optical control as well. This allows the
combination of more inputs and outputs for the dimerization of PYL and ABI.
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2.4 Methods

Materials
Restriction enzymes and polymerases were purchased from NEB. Cell
culture plates and tubes are from Grenier-Bio One. Cell culture reagents such as
media, trypsin, and PBS were purchase from Gibco. Chemicals were purchased
from Sigma unless otherwise noted.

Caged ABA Synthesis
Chemicals and instruments:
Bulk solvents were obtained from EMD. (+)-Abscisic acid was obtained
from Gold Biotechnology. 4,5-Dimethoxy-2-nitrobenzylbromide was obtained
from Sigma-Aldrich. These compounds were used directly without further
purification. Other chemicals are commercially available. NMR spectra were
recorded on a Bruker instrument (300 MHz). Mass and NMR spectra for new
compounds were recorded at the Mass Spectrometry and NMR Facilities,
Department of Chemistry and Chemical Biology, University of New Mexico.

Synthesis of ABA-DMNB
4,5-Dimethoxy-2-nitrobenzyl bromide (DMNB; 303.6 mg, 1.2 mmol) was added to
a CH2Cl2 solution of abscisic acid (ABA; 264 mg, 1 mmol) and 1,8diazabicyclo[5.4.0]undec-7-ene (DBU; 168 mg, 1.2 mmol) at room temperature.
After 2h, the solution was concentrated under vacuum. A pale yellow powder was
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obtained after purification by silica gel column chromatography using
hexane/ethyl acetate (v/v= 1: 1) as an eluting solvent (Rf= 0.5). Yield: 94 %. 1H
NMR (300 MHz, CDCl3): 7.89-7.84 (d, J= 15.9 Hz, 1H), 7.70 (s, 1H), 7.00 (s, 1H),
6.20- 6.15 (d, J= 15.9 Hz, 1H), 5.90 (s, 1H), 5.82 (s, 1H), 5.53 (s, 2H), 3.96 (s,
3H), 3.94 (s, 3H), 2.48-2.25 (dd, J= 17.1, 54 Hz, 2H), 2.06 (s, 1H), 2.02 (s, 3H),
1.88 (s, 3H), 1.63 (s, 1H), 1.08 (s, 3H), 0.99 (s, 3H). 13C NMR (100.6 MHz,
CDCl3): 197.72, 165.31, 162.45, 153.59, 150.87, 148.38, 140.17, 137.18, 128.01,
127.30, 127.13, 117.64, 110.83, 108.38, 79.72, 62.91, 56.53, 49.87, 41.60,
24.45, 23.16, 21.41, 18.94. TOF-HRMS (m/z) found (calcd.) for C24H29NO8 (M):
[M+Na]+, 482.1790 (482.1791).

Synthesis of ABA-DEACM
A CH2Cl2 solution of abscisic acid (ABA; 264 mg, 1 mmol), EDC (230 mg, 1.2
mmol) and DMAP (catalytic amount) was stirred 10 min at room temperature, to
which compound 3 (299 mg, 1.2 mmol) was added. Compound 3 was
synthesized according to the literature.[1] The reaction was then stirred overnight
at room temperature. The organic solution was washed three times with sodium
bicarbonate (saturated aqueous solution), dried over sodium sulfate and
concentrated under vacuum. A yellow powder was obtained after purification by
silica gel column chromatography using hexane/ethyl acetate (v/v= 1: 1) as an
eluting solvent (Rf= 0.47). Yield: 82 %. 1H NMR (300 MHz, CDCl3): 7.93-7.88 (d,
J= 15.9 Hz, 1H), 7.30-7.27 (d, J= 9 Hz, 1H), 6.60- 6.56 (d, J= 11.4 Hz, 1H), 6.51
(s, 1H), 6.23-6.18 (d, J= 15.9 Hz, 1H), 6.21 (s, 1H), 5.93 (s, 1H), 5.85 (s, 1H),
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5.26 (s, 2H), 3.44-3.37 (q, J= 21.3 Hz, 4H), 2.51-2.27 (dd, J= 17.1, 57 Hz, 2H),
2.05 (s, 3H), 1.92 (s, 3H), 1.75 (s, 1H), 1.23-1.18 (t, J= 14.1 Hz, 6H), 1.11 (s,
3H), 1.02 (s, 3H). 13C NMR (100.6 MHz, CDCl3): 197.77, 165.18, 162.48,
162.25, 156.36, 151.25, 150.78, 149.85, 137.32, 128.18, 127.20, 124.46, 117.49,
108.83, 106.39, 106.16, 97.97, 79.81, 61.12, 49.92, 44.89, 44.66, 24.50, 23.17,
21.49, 12.56. TOF-HRMS (m/z) found (calcd.) for C29H35NO6 (M): [M+Na]+,
516.2360 (516.2362).

HPLC Analysis
Reversed-phase HPLC was performed on a Dionex Acclaim 120 (4.6 x
100mm) C18 column using an UltiMate 3000 pump system that included Variable
Wavelength Detector 3100, Degasser 1210, and Autosampler SPS 3000.

A

mixture of water and acetonitrile containing 0.1% TFA was used as the eluent.
Absorbance at 250 nm was used to monitor the elution of the molecules. The
method used an increase in acetonitrile from 5% to 95% over 15 min to elute the
molecules at a flow rate of 0.7 mL/min.

The peaks for the molecules were

integrated using Chromeleon software. The molar absorptivity of both free and
caged ABA at 250 nm was measured, which was used to calculate the
concentration of each species from the intensity of absorbance at 250 nm. The
relative concentration of each compound was used to calculate the percent
concentration of free ABA relative to the concentration of total ABA species (both
caged and uncaged).
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Cell Culture and Transfection
CHO cells and 293T EGFP reporter cells (provided by Dr. Gerald R.
Crabtree) were cultured in Dulbecco’s modified Eagle’s medium (DMEM) (Gibco)
with

10%

FBS

(Atlanta

Biologicals),

1x

GlutaMAX

(Gibco),

and

1x

penicillin/streptomycin (Pen/Strep; Gibco). Cells (15,000 to 50,000) were plated
in wells of a 24- or 8-well plate for 24 h before transfection. DNA constructs (0.1
µg to 0.5 µg) were added to 50x (v/w) Opti-MEM (Gibco) and then 3x (v/w) PEI
(Polysciences) was mixed with the DNA. The mixture was incubated for 20 min at
the room temperature before adding it to cell cultures. The cells were grown for 1
day after transfection before experiments were performed.

DNA Plasmids Construction
The construction of the 5FL, 5IG, SV-VPiGA, NES-ABI, GFP-PYL, myrABI plasmids has been described previously (6). PYL-EGFP-Tiam1 construct
was derived from pSV40-VP16-PYL-IRES-Gal4DBD-ABI by inserting codon
optimized

PYL

fragment

(PCR

amplified

by

primers

CCGACAGAATTCGCCACCATGACCCAGGACGAGTTTACCCAG

and

CCGACAGGCGCGCCGCTGCCGCCGTTCATAGCCTCAGTAATGCT)
EcoRI and AscI sites, Tiam1-SG linker fragment

(amplified

by

GCTATGAACGGCGCGCCA-AGTGCTGGTGGTAGTGCTGGT

using
primers
and

CTAGAGTCGCGGCCGCTCAG-ATCTCAGTGTTC-AGTTTC) using AscI and
NotI

sites,

and

EGFP-SG-linker

fragment

CCGACAGGCGCGCCAG-
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(amplified

by

primers

GTGGATCTGGAGGTTCAGGTGGATCTGGAGGTGTGAGCAAGGGCGAGGAG
CTG and CCGACAGGCGCGCCCTTGTACAGCTCGTCCAT-GCC using AscI
site.

Photoirradiation
Irradiation at 365 nm was performed using an Axio Observer (Zeiss)
microscope with an HBO103 W/2 mercury arc lamp. Irradiation was performed
using the DAPI filter set with peak excitation at 365 nm (power density 23
mW/cm2) and spectral width of 50 nm. No objective lens was used for whole-well
irradiation, which created an area of illumination that nearly completely covers
one well of a 24-well plate. Light was transmitted through the bottom of the well
of polystyrene plate. Irradiation at 405 nm was performed using an Adjustable
Focus Violet Purple Laser Pointer (LazerPoint SKU 0733579) with excitation
wavelength of 405 nm and 1000 mW intensity positioned 8 cm above the bottom
of either a 96- or 24-well plate and irradiated through the polystyrene lid. All
samples for HPLC analysis were irradiated in DMSO to prevent evaporation of
solvent and changes in sample concentration. Irradiation of cell cultures was in
24-well plates containing 500 µL of culture media.

Luciferase Assay
Cells from 24-well plates were washed with PBS and lysed with 100 µL of
Reporter Lysis Buffer (Promega) by incubating and gently shaken at room
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temperature for 10 min after a freeze/thaw cycle. Cell lysates were centrifuged at
15,000 rpm in an Eppendorf Centrifuge 5424 and 25 µL of lysate was used for
luciferase assay. 100 µL of luciferase assay reagent (5 mg luciferin (GoldBio)
and 7 mg coenzyme A (Sigma) in 33 mL of luciferase assay buffer [20 mM
tricine, 1.07 mM (MgCO3)4Mg(OH)2•5H2O, 2.67 mM MgSO4, 0.1 mM EDTA,
33.3 mM dithiothreitol, and 0.53 mM ATP in water) was added to lysates.
Luciferase assay reagent was added through the auto-injector of GLOMAX-Multi
Detection System (Promega), and the signal was detected by the instrument with
a 1.5 s delay and 0.5 s integration time. All experiments were conducted in
triplicate.

Slide Preparation
Cells were grown on glass coverslips in 24-well plates. The coverslips
were washed with phosphate-buffered saline (PBS) and fixed with 300 µL of 4%
paraformaldehyde (PFA, prepared in PBS) at room temperature for 20 min. The
cells were then washed twice with PBS and incubated with 1x DAPI in the dark at
the room temperature for 5 min. After a final wash with PBS, the coverslips were
mounted on a glass slide with Vectashield (VWR) mounting media and allowed to
stand for 2 h in the dark before imaging.
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Fluorescence Microscopy Imaging
Slides were imaged with Axio Observer (Zeiss) microscope or with Zeiss
LSM 510 Meta confocal mounted on an AxioObserver inverted microsope using
the 63x oil objective. Images were taken with DAPI and GFP channels.

Live Cell Confocal Microscopy Irradiation and Imaging
EGFP fluorescence of CHO cells was detected with a Zeiss LSM 510
Meta confocal mounted on an AxioObserver inverted microscope. The ABADEACM was uncaged using the 405 nm UV laser (25 mW) set to 25% power for
around 3 sec. To image, fluorescence was excited with the 488 nm line of an
argon laser (30 mW) with laser power attenuated to 50%. EGFP emission was
collected with a FITC filter. Live cells were plated in 8-well coverslip-bottom
culture chambers in 200 µL media and maintained at 37 °C with an objective lens
heater (Bioptics). Culture medium was exchanged to OptiMEM (Gibco) with
caged ABA, or no drug prior to imaging. Images were acquired every 10 to 20
sec in different experiments with a 63x/ 1.2 NA water objective.

Statistical Analysis of Cell Population
Cells were categorized as displaying nuclear export of EGFP when the
fluorescent intensity of the nucleus was less than 60% of the intensity of the
cytoplasm.

Cells were categorized as Ruffled when they displayed broad

extensions identifiable as lemellopodia or fillopodia from the GFP fluorescence
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from membrane localized EGFP-PYL-Tiam1. Cells were counted from three
separate experiments with N > 50 for each experiment.
Image Analysis of Fluorescence Intensity in Nuclear Export Experiments:
Images generated were analyzed for fluorescent intensity using Slide Book v.6
software. Equal sized regions of interest were analyzed from the cytoplasm and
the nucleus to compare fluorescent intensity of EGFP in three cells for each
condition from images taken every 20 sec for duration of 20 min.
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Chapter 3 – Chemically Inducible Translation

3.1 Introduction
I want to use ABA based dimerization to initiate the translation of a
specific reporter gene. To do this I want to use the dimerization event to bring
the translation initiation complex into proximity of a specific mRNA. I will fuse an
RNA binding protein fused to one of the dimerizing proteins and a translation
initiation factor to the other dimerizing protein. This should allow the recruitment
of the ribosome to an mRNA only when ABA is present.
Protein components of the translation initiation complex have been fused
to RNA binding proteins to target their function directly to the mRNA. This has
been used to separate the RNA binding domains from the translation regulation
domains. The C-terminus of eIF4G was fused to RNA binding domains to target
translational machinery to reporter genes (1). Truncated versions of eIF4G that
had any parts of the eIF4A binding sites removed were less effective at inducing
translation, Figure 3.1 (1). This indicates that the C-terminus of eIF4G would be
the best candidate for recruiting the translation initiation complex. Expression of
any of the proteins containing the RNA binding domain without eIF4G had no
effect on the level of reporter mRNAs indicating that the increase in translation is
specific to the sequence of the RNA and the corresponding RBP-eIF4G fusion
protein (1).

88

Figure 3.1. The section of eIF4G that is most effective at inducing translation is from amino acid
642 to 1560. Truncated versions were less effective. (1)

The RNA stem loop and RNA binding domain pair are interchangeable for
tethering the function of eIF4G, and it was shown that multiple pairs of RNA stem
loops and RNA binding proteins could both be used to elicit translation of the
downstream gene (1).

Although any stem loop/protein pair can induce

translation there could be drawbacks to using the iron-responsive protein in that
the iron-responsive element is found in the 5’ and 3’ UTR of quite a few mRNAs
(2).
λN, a protein from the Lambda bacteriophage, is an antiterminator that
binds regions within the viral genome to allow the read through of termination
sites and promote transcription of downstream genes (3). In these sites there is
a 15 nucleotide palindromic sequence, BoxB, capable of folding into a hairpin
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loop, and it is this RNA structure that binds the λN protein (4). Only the first 22
amino acids of λN are required for binding (5). In addition to binding the loop
sequence the protein binds asymmetrically to only the 5’ arm of the BoxB stem
(6).
MS2 coat protein (MCP) is a common protein used to target mRNA
binding.

MCP is responsible for forming the capsid of the MS2 virus.

This

protein also regulates the translation of a viral replicase gene that contains an
MS2 stem loop in the 5’UTR (7). Fusion proteins between MCP and GFP have
been used to track the location of transcripts containing the MS2 stem loop (8).
There is an equilibrium between the dimer of MCP that binds the stem
loop and oligomerization that forms the viral capsid. When capsids are formed
MCP is unable to bind the mRNA and repress translation (9). There is a flexible
15 amino acid loop between the F and G β-strands of the monomer that is
involved in the contacts important for the formation of the capsid. Deletion of the
FG loop causes the protein to not be able to form capsids (10). A mutation of
valine 29 to isoleucine created a protein that was able to repress translation
better than the wild type protein, but was still able to assemble into capsids (11).
It was later shown that the V29I mutant binds more tightly to wild type and mutant
stem loops (12).
MCP dimerizes and creates a large β-sheet composed of 5 β-strands from
each protein, and binds the MS2 loop with this surface. The C-terminus of one
monomer is in close in proximity to the N-terminus of the other monomer (13).
The production of MCP as a fused dimer with an amino acid linker is able to bind
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the MS2 sequence and suppress translation (14). The duplicated protein has the
same binding affinity as the wild-type protein (14).
The design of the intercistronic region of the reporter mRNA is important
for inducing translation. The spacing between the first gene and the stem loops
influences the amount that the second gene can be translated. Having only 70
base pairs gives nearly three-fold increase in translation, while having 136 base
pairs increases that to four-fold (1). The distance between the stem loops and
the second gene is also important. Decreasing that distance from 46 base pairs
to 13 showed a negative effect upon the translation of the second gene (1). The
spacing used in previous experiments may or may not be optimal for our system
because of the increased distance between the RNA binding domain and eIF4G
because of the addition of the dimerizing protein pair.
The identities of the nucleotides in the MS2 loop are most important for
binding to the coat protein. There is an unpaired adenosine two base pairs
upstream from the loop that is also important for binding (15). There also should
be at least three paired nucleotides below the bulge for optimal structure (9). An
MS2 stem loop that has a mutation of a C at the -5 position binds the coat protein
150 better than the wild type loop sequence (16). A factor that has a large
influence on the amount of translation of the downstream gene is the number of
stem loops present. Increasing the number of RNA stem loops, from 1 to 3, in
the reporter construct has a two-fold increase in translation, Figure 3.2A (1).
The first gene of the reporter construct did not show any change in
expression from the translation of the downstream gene.
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Translation of the

downstream gene is not affected by the repression of cap-dependent translation
from a large stem loop in the 5’UTR.

The induction of translation of the

downstream gene is 10-15% as efficient as the hepatitis C viral IRES, Figure
3.2B, and is about 5% as efficient as cap-dependent translation.

The

background translation of the second gene without induction is about 0.7% that
of the upstream gene (1).

Figure 3.2. (A) An increasing number of stem loops in the reporter construct causes and increase
in translation of downstream genes. (B) The HCV IRES was found to be more effective for
inducing translation than RBP based targeting of eIF4G. (1)

I want to use ABA inducible dimerization as a switch to control the
translation of a gene downstream of an RNA stem loop. I want to do this by
using the dimerization to control the proximity of eIF4G to RNA binding protein
that targets the mRNA with corresponding RNA stem loop, Figure 3.3. To make
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the system I will fuse one of the PYL and ABI dimerizing pair to either the RNA
binding protein or eIF4G.

These proteins can be expressed constantly, but

should not elicit a response until ABA is present.

Figure 3.3 . Strategy for engineering ABA inducible translation. The translation of GFP occurs
when eIF4G is recruited to the RNA sequence upstream from it. An RNA binding protein is used
to target a specific sequence and bring eIF4G into proximity upon dimerization of PYL and ABI.

Using a chemical activator allows fast control of dimerization and could
allow greater precision of translation compared to direct fusion proteins.

In

addition it could be possible to combine this with the photorelease of ABA in
order to spatially control the activation of translation of a specific protein. This
could be used to produce a biologically relevant protein sub-cellularly to
investigate its role neural growth and function.
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3.2 Results
I am going to use a system that employs a reporter construct expressing
fluorescent proteins. Similar to previous work I will put one gene under normal
cap-dependent translation and the other will be downstream of an RNA stem
loop that can bind an RBP to target the localization of eIF4G. In this way I can
use the fluorescence intensity of each of the reporter proteins as measure of the
relative amounts of cap-dependent and cap-independent translation.

Optimizing the Reporter Construct
RNA binding domains from viruses were used to target RNA sequences
because they are not used in normal cellular contexts.

The RNA binding

domains were fused to the C-terminal region of eIF4G containing amino acids
642-1560 with a flexible linker in between. I created direct fusion proteins that
have one or two copies of MCP, as well as one that contained two copies of the
λN protein, Figure 3.4.
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Figure 3.4. The RNA binding proteins MCP and λN were fused to C-terminal domain of eIF4G
containing amino acids 642-1560. The MCP protein was fused to eIF4G as both a monomer
(MCP-eIF4G) and a dimer (2xMCP-eIF4G). The λN protein was used as a dimer but is the only
one so is called λN-eIF4G.

The reporter constructs have an mCherry gene that is translated through
normal cap-dependent processes as a control for expression levels of the
reporter construct. Downstream of this gene is a 70 nucleotide spacer before the
stem loops and then a 40 nucleotide spacer after the stem loops and before the
inducible GFP gene. I created several versions of the reporter construct that
contained either one or three copies of the MS2 stem loop, Figure 3.5. These
constructs were named mCherry-MS21-GFP (CM1G) and mCherry-MS23-GFP
(CM3G).
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Figure 3.5. The MS2 insert from pCR4-24XMS2SL is shown restricted with MluI. The enzyme
cuts in the middle of an stem loop such that ligation of two fragments rejoins the two halves of the
MS2 sequence. Therefore there are MS2 reporter constructs with one (MS21) and three (MS23)
stem loops.

I made a reporter construct with the BoxB sequence instead of the MS2
sequence to test the specificity of the RNA binding domains for their respective
reporters, Figure 3.6. The λN protein should not be able to bind the MS2 stem
loop and vise versa.
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Figure 3.6. Reporter constructs contained MS2 or BoxB stem loops downstream of the mCherry
coding sequence and upstream of the GFP coding sequence. These were used to compare the
fluorescence of mCherry compared to GFP for each condition.

I wanted to make a BoxB construct with two stem loops in order to bind
the two λN proteins fused to eIF4G. I wanted to create these so that I could
compare the use of multiple RNA-protein contacts to increase the interaction. I
initially ordered a double stranded DNA fragment (IDT) containing two copies of
the BoxB stem loop, but with one stem sequence changed to avoid repetitive
sequences to facilitate synthesis of the DNA. Because the λN protein binds the
stem as well as the loop this would essentially only make one function copy of
BoxB and therefore this construct was named mCherry-BoxB1-GFP (CB1G). I
made another BoxB reporter containing two stem loops using short
oligonucleotides of the BoxB sequence, Figure 3.7, and this construct was
named mCherry-BoxB2-GFP (CB2G).
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Figure 3.7. BoxB stem loops were designed to not have similarity in the stem sequence so that it
doesn’t form other secondary structures.

The λN protein binds the 5’ region of the stem, and

hence the second BoxB stem loop (green/yellow) may not bind λN.
construct with this sequence is mCherry-BoxB1-GFP (top).

Therefore the reporter

Two copies of a DNA fragment

containing the BoxB stem loop (blue/red) were inserted into a reporter plasmid to give mCherryBoxB2-GFP (bottom).

Testing the BoxB reporters: B35 cells were transfected with the either
one of BoxB reporter constructs and the λN-eIF4G construct and grown for 24
hours. The mCherry-BoxB2-GFP construct showed almost no ability to induce
the translation of GFP in the presence of λN-eIF4G, Figure 3.8. This may be due
to the formation of larger RNA structures involving pairing between the two
copies of the BoxB sequences. It may be that the 5’ side of the first stem of the
first sequence (blue in Figure 3.5) would bind the 3’ side of the stem of the
second sequence (red in Figure 3.5) creating a RNA structure that would not
resemble the three dimensional structure necessary to bind λN.
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Figure 3.8. B35 cells were transfected with the BoxB reporter constructs mCherry-BoxB1-GFP
(CB1G) and mCherry-BoxB2-GFP (CB2G). These cells were either transfected with λN-eIF4G
(λNIF) or no inducer. Cells with λNIF and CB1G showed increased translation of GFP compared
to cells with λNIF and CB2G. This may be due to the formation of a different secondary structure
of the BoxB stem loops when there are two exact copies.

Testing the reporter specificity: B35 cells were transfected with one of
the eIF4G fusion proteins and one of the reporter constructs. All of the eIF4G
fusion constructs were tested against all of the reporter constructs to see if the
binding was specific to the corresponding stem loop and protein, Figure 3.9. The
relative induction of translation was calculated by getting the ratio of the
fluorescence of GFP over mCherry for each condition. The relative induction of
each condition was normalized by dividing by the relative induction of translation
of a negative control to get the fold change in translation of GFP. This was
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normalized to the relative induction of translation for the negative control with the
lowest background, in this case CB1G, Figure 3.9.

Figure 3.9. Flow cytometry analysis shows the amount translation induction from different
combinations of reporter constructs and eIF4G fusion proteins.

There was an increase in

translation of GFP when MCP-eIF4G (MIF) or 2xMCP-eIF4G (2MIF) were cotransfected with
either mCherry-MS21-GFP (CM1G) or mCherry-MS23-GFP (CM3G) compared to background
levels. An increase was also increase of translation when λN-eIF4G (λIF) is cotransfected with
mCherry-BoxB1 –GFP (CB1G). Translation of GFP occurs only when the eIF4G fusion protein is
present with the corresponding stem loop reporter. There are low levels of translation of GFP
when an eIF4G fusion protein is present that does not bind the reporter sequence showing that
GFP translation is not a result of overexpression of eIF4G.

The expression of GFP from the CM1G reporter construct was slightly
higher than that of the CM3G reporter construct.

This may be due to a

decreased ability to block the ribosome from scanning through the intercistronic
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distance. The presence of the additional MS2 stem loops creates more of a
barrier to the ribosome to decrease background translation of GFP.

The

expression of GFP greatly increases when MS2 containing reporter constructs
are expressed with MCP-eIF4G fusion proteins, while the expression of GFP also
increases when the BoxB1 reporter construct is expressed with the 2xλN-eIF4G
fusion protein. Importantly, there is little expression of GFP when MS2 reporter
constructs are used with the λN-eIF4G fusion protein or when the BoxB1 reporter
construct is used with the MCP-eIF4G fusion proteins.

This shows that the

translation is dependent upon the RNA binding protein’s specific interactions with
the corresponding RNA stem loop sequence and can be specifically targeted.
There are slightly higher fold change in translation of GFP when either of
the MCP fusion proteins are used with CM1G compared to CM3G, this may be
due to the slightly higher background expression of the GFP gene when there is
just one stem loop. Therefore some of the GFP signal is from the carry over of
the ribsome from mCherry and is not specific to the localization of the MCPeIF4G fusion proteins to the stem loops.
Testing the MS2 reporters: In another experiment the MCP direct fusion
proteins were co-transfected with the reporter constructs either containing one
MS2 stem loop or three MS2 stem loops. This time each data set, either CM1G
or CM3G, was normalized separately to its background levels of GFP.

The

relative induction of MIF’s with CM1G was divided by the relative induction of PIF
with CM1G, and the relative induction of MIF’s with CM3G was divided by the
relative induction of PIF with CM3G, In this way I could see which reporter
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construct and inducer construct pair gave the greatest change in translation
induction, Figure 3.10. It was shown that the constitutive dimer of MCP fused to
eIF4G was able to induce slightly more translation of GFP compared to the
monomer. The CM3G reporter construct had a greater fold change in translation
compared to CM1G when normalized in this manner compared to normalization
of all of the reporter constructs to the lowest negative control.

Figure 3.10. Whole well analysis was used to measure the amount translation induced for each
MS2 reporter construct. Each construct was normalized by its own value for the negative control
with PYL-eIF4G. In this way one can see the amount of change in translation for each construct
from localization of MCP-eIF4G proteins. It was shown that mCherry-MS23-GFP (CM3G) has the
highest amount of change in the translation of GFP compared to its background levels.
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Testing the effects of installing a repressor loop: I also created a
reporter construct with an additional stem loop that is 24 nucleotides in length
and has been shown to decrease cap-dependent translation by over 96% (1),
Figure 3.11.

I wanted to see if the system could be optimized by further

suppression of the basal translation of the second gene. The repressor loop was
installed downstream of the mCherry sequence and directly upstream from the
MS2 fragment, which puts it over 70 nucleotides from the first MS2 stem loop.

Figure 3.11. The 24 base pair repressor loop was inserted directly upstream of the MS2 insert to
decrease ambient translation of GFP.

Cells were transfected with either the mChery-MS23-GFP (CM3G) or the
repressor loop reporter mCherry-RL-MS23-GFP (CRLM3G) in addition to the
direct fusion inducer 2xMCP-eIF4G or one of the split constructs PYL-eIF4G or
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2-MCP-ABI. When whole well fluorescence was analyzed it showed nearly the
same levels of background expression of GFP, Figure 3.12. The repressor loop
reporter construct also showed lower levels of GFP expression when induced
with 2xMCP-eIF4G. The decrease fold change of translation using the repressor
loop construct may be due to placement of the eIF4G upon binding.

Upon

binding the MS2 stem loop, the MCP-eIF4G protein could be oriented upstream
or downstream. If the eIF4G is positioned upstream from the repressor loop, that
loop will block the advancement and scanning of the ribosome. This could be the
reason for the decrease in translation activation of the repressor loop construct.

Figure 3.12. Flow cytometry analysis of B35 cells transfected with either the mChery-MS23-GFP
(CM3G) or the repressor loop reporter mCherry-RL-MS23-GFP (CRLM3G) shows that the
repressor loop constructs shows similar levels of background when cotransfected with PYLeIF4G (PIF) or 2xMCP-ABI compared to the construct without the repressor loop. The repressor
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loop construct does show lower levels of GFP expression when induced with 2xMCP-eIF4G
(2MIF).

Optimizing ABA Inducible Translation

Next I wanted to employ chemically induced dimerization as a switch to
localize eIF4G to the mRNA upon addition of the activator. Therefore I created
MCP-ABI fusion proteins and used them in conjunction with PYL-eIF4G to create
an ABA inducible translation system. I made both the MCP monomer and dimer
fused to ABI for targeting the mRNA in ABA induced translation, Figure 3.13.

Figure 3.13. The ABA dependent dimerizing proteins ABI and PYL were fused to MCP and eIF4G
domains to create ABA dependent translation.

Testing ABA inducible translation: B35 cells were transfected with the
MCP-ABI and PYL-eIF4G constructs as well as the CM3G reporter. Cells that
received ABA showed an increase in GFP translation compared to cells that did
not receive ABA Figure 3.14.
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Figure 3.14. B35 cells were transfected with MCP-ABI and PYL-eIF4G along with the mCherryMS23-GFP reporter construct. Cell incubated with 100µM ABA for 24 hours showed an increase
in GFP fluorescence compared to cell that did not receive ABA.

I wanted to see which of the MCP-ABI fusion proteins showed greater
induction of translation from the addition of ABA. Cells were transfected with
PYL-eIF4G, either MCP-ABI or 2xMCP-ABI, and either CM1G or CM3G. Without
ABA the reporter CM1G and MCP-ABI show the highest levels of background,
and also show the highest fold change in translation of GFP with ABA when
normalized to the lowest negative control, in this case CM3G with 2xMCP-ABI
and PYL-eIF4G without ABA, Figure 3.15. The CM1G construct shows lower
levels of background translation of GFP with the 2xMCP-ABI protein. The levels
of background without ABA and induction with ABA were similar when using the
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CM3G reporter construct with either of the MCP-ABI fusion proteins. It may be
that there is better binding with the MCP fused dimer with the stem loop, which
decreases the read through of the ribosome from mCherry.

Figure 3.15. Whole well fluorescence analysis of B35 cells that had been transfected with either
MCP-ABI (MA) or 2xMCP-ABI (2MA) along with PYL-eIF4G (PIF) and the reporter mCherryMS23_GFP (CM3G). There was low expression of GFP when there is no ABA present, but
shows increased levels of GFP when incubated with 100µM ABA.

Testing transfection ratios for PYL-eIF4G and 2xMCP-ABI: I wanted to
make a bicistronic construct containing both halves of the dimerizing system. I
thought that this would improve the system by increasing the probability that a
cell will get all three components necessary for ABA inducible translation. The
use of the hepatitis C virus (HCV) IRES allows the production of both proteins
from the same mRNA transcript, thus assuring co-expression.
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Translation from an IRES is still not quite as strong as normal capdependent translation, and so the second gene will always have slightly lower
amounts. I wanted to find out which gene should come first and which should
come second, so I tested the amount of induction from relative amounts of each
constructs, Figure 3.16.

Figure 3.16. B35 cells transfected with mCherry-MS21-GFP (CM1G) or mCherry-MS23-GFP
(CM3G) and different ratios of 2xMS2-ABI (2MA) and PYL-eIF4G (PIF). Cells were analyzed by
whole well fluorescence to find optimal ratios for the dimerizing proteins 2MA and PIF. Fold
change of translation is normalized to negative controls without ABA for each transfection
condition. There is a greater amount of change in translation of GFP when greater amounts of
PYL-eIF4G are transfected compared to 2xMCP-ABI.
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I transfected cells with different ratios of DNA for the inducer constructs. I
used .1µg of DNA for the reporter construct for each condition, but varied the
amount of DNA for 2xMCP-ABI and PYL-eIF4G. I used ratios of 4:1, 1:1, and
1:4, in which the total amount of inducer construct DNA was equal to 0.5µg. I
took half the transfected cells and added 10µM ABA and incubated for 24 hours.
I then normalized each transfection condition with ABA to the same transfection
condition without ABA as the negative control to get the fold change for ABA
induced translation.
I found that the amount of translation of GFP increased the most when
the amount of PYL-eIF4G transfected was the greatest, Figure 3.16. Therefore I
concluded that the PYL-eIF4G would go before the IRES and the 2xMS2-ABI
gene should go after the IRES, Figure 3.17.

Figure 3.17. PYL-eIF4G was inserted upstream from the IRES to attempt to have higher
expression of this protein. 2xMCP-ABI was inserted downstream from the IRES, which will cause
lower levels of expression of this protein.

Testing the bicistronic inducer construct: I wanted to test the
effectiveness of duel transfection with the bicistronic construct and the reporter in
comparison to triple transfection with all of the components on separate
plasmids.

B35 cells were transfected with the CM3G reporter construct and
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either the bicistronic incuder PIFi2MA or the two constructs 2MA and PIF used in
a 1 to 4 ratio. Fluorescence analysis of the whole well showed that the amount
of translation of GFP induced with the PIFi2MA construct was greater than that of
the separate constructs 2MA to PIF, and nearly reached that of the positive
control with 2MIF, Figure 3.18. This may be due to the fact that the positive
control scenario only requires the acquisition of two plasmids for a cell to be able
to translate GFP, which is more likely than aquiring all three plasmids.

Figure 3.18. Whole well fluorescence was used to analyze the effectiveness of the bicistronic
inducer construct. Cells transfected with the mCherry-MS23-GFP (CM3G) reporter construct and
the bicistronic inducer, PYL-eIF4G-ires-2xMCP-ABI (PIFi2MA), showed a greater fold change of
ABA dependent GFP translation than the separate constructs 2xMS2-ABI (2MA) and PYL-eIF4G
(PIF). The bicistronic inducer does show a slight increase in the background translation of GFP,
similar to the cells transfected with only PYL-eIF4G.
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I repeated this experiment using the flow cytometer and expected to get
similar results seen in whole well analysis.

When the amount of translation

induction was calculated with the flow cytometer a different pattern was
observed.

The cells that induced translation with all three plasmids showed

greater GFP expression than those transfected with the bicistronic inducer,
Figure 3.19. These results reveal that on a per cell basis the bicistronic inducer
is less effective, but on a whole well level it is more effective.

Figure 3.19. Flow cytometry was used to further analyze the bicistronic inducer’s effectiveness.
Cells were transfected with the reporter construct mCherry-MS23-GFP and either the bicistronic
inducer PYL-eIF4G-ires-2xMCP-ABI (PIFi2MA) or separate constructs 2xMCP-ABI (2MA) and
PYL-eIF4G (PIF). The levels of ABA induced GFP expression per cell are greater for those
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transfected with the seperat constructs for 2MA and PIF compared to the ABA induction from the
bicistronic inducer PIFi2MA.

This lead me to look into the amount of cells in each condition that show
GFP expression above backgound levels. The bicistronic construct causes more
cells to be able to translate GFP ,Figure 3.20, but to a lesser intensity per cell
than transfecting the constructs seperately at a 1 to 4 ratio of 2MA to PIF as seen
in Figure 3.19.

Figure 3.20. Cells were transfected with the reporter construct mCherry-MS23-GFP and either
the bicistronic inducer PYL-eIF4G-ires-2xMCP-ABI (PIFi2MA) or separate constructs 2xMCP-ABI
(2MA) and PYL-eIF4G (PIF). Further analysis from flow cytometry shows the percentage of cells
in each condition that have GFP fluorescence greater than background levels (green box). The
bicistronic inducer construct causes more cells to increase their translation of GFP compared to
transfection with separate constructs when incubated with 100µM ABA.
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Characterizing ABA Inducible Translation
I wanted to determine the optimal conditions to use for inducing translation
of GFP. I wanted to see if there was a time point after the addition of ABA that
would show high induction of GFP translation and low background translation of
GFP without ABA. I also wanted to see how rapidly the system could elevate
levels of GFP above background levels. In addition I wanted to see if there was
a correlation between the concentration of ABA and the amount of GFP
produced, similar to the results seen from ABA induced transcription.

Figure 3.21.

Cells were transfected with the reporter construct mCherry-MS23-GFP the

bicistronic inducer PYL-eIF4G-ires-2xMCP-ABI (PIFi2MA). Cells were incubated with ABA in a
range of concentrations from 1nM to 100µM for 24 hours. An increase in the expression of GFP
was seen with increasing ABA concentration.
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Testing optimal ABA concentration: B35 cells were transfected with the
CM3G reporter construct and the bicistronic inducer construct PIFi2MA. A wide
range of ABA concentrations were used, from 1 nM to 100 µM. There was an
increase in the amount of GFP with an increase in concentration of ABA, Figure
3.21. Cells analyzed with flow cytometry showed an increase of fold change in
translation for concentration up to the µM range, Figure 3.22.

Figure 3.22.

Cells were transfected with the reporter construct mCherry-MS23-GFP the

bicistronic inducer PYL-eIF4G-ires-2xMCP-ABI (PIFi2MA). Cells were incubated with ABA in a
range of concentrations from 1nM to 100µM for 24 hours. Flow cytometry analysis confirms that
there is a relationship between ABA concentration and GFP expression. The peak responses are
in the µM range of ABA, and induction of GFP translation drops off in the low nM range.
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Testing the time course of protein translation: I wanted to measure the
responsiveness of the system to ABA and so measured the induction of
translation after incubating for various timepoints and various concentrations.
ABA was added to cell cultures 12 hours after transfection with CM3G and
inducer constructs in order to give cells time to produce inducing proteins. The
cells transfected with the direct fusion construct already showed robust
expression of GFP. The cells were collected at various time points after the
addition of ABA at a concentration of 10µM. Translation of GFP increases above
background levels after 6 hours after the addition of ABA, and reaches its
maximum fold change in translation after twelve hours, Figure 3.23.

The

absolute level of GFP continues to increases after 12 hours, but the absolute
levels of mCherry may be increasing faster such that the ratio of GFP
fluorescence over mCherry fluorescence decreases past that time point.
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Figure 3.23.

Cells were transfected with the reporter construct mCherry-MS23-GFP and the

bicistronic inducer PYL-eIF4G-ires-2xMCP-ABI (PIFi2MA). Cells were incubated with ABA at a
concentration of 10µM or given no ABA. Levels of translation peak 12 hours after the addition of
ABA to cell cultures transfected with the reporter and inducer constructs.
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3.3 Conclusion and Discussion
Reporter constructs were created to measure the difference in the amount
of cap-dependent translation compared to induced cap-independent translation.
GFP was expressed when the translational machinery was targeted to a specific
RNA structure upstream from the start codon. RNA binding proteins from viruses
were used to target cognate RNA stem loop structures. These proteins were
either directly fused to the ribosome recruiting domain of eIF4G or two one of the
dimerizing pair.

In this way I could control the proximity of the translational

machinery to the GFP sequence.
Chemically inducible dimerization from ABA is capable of controlling capindependent translation.

Fusion of the ABI protein to an MCP RNA binding

domain targets the system to a MS2 stem loop, while fusion of the PYL protein to
eIF4G, amino acids 642 to 1560, recruits the translation machinery. Addition of
ABA dimerizes the proteins bringing the translation complex to a gene
downstream of the RNA binding site initiating the production of the downstream
GFP gene.
The stem loops and RNA binding proteins can be interchanged and
optimized to increased translation of the reporter gene. In addition, combing both
genes for the inducer proteins into one bicistronic construct allows better
expression of the system. Further work to control the trafficking of the inducer
proteins and the reporter mRNA could be used to allow sub-cellular regulation of
translation.
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The system induces the translation of the reporter gene to visible levels
within hours of induction.

The intensity of translation expression can be

controlled by the dosage of ABA used. The intensity of activation of the system
can be tuned by controlling how much ABA is present and for how long. This
could be used to allow translation of a gene at a specific time and at a desired
intensity to modulate biological events.
Chemically induced dimerization has been used to control biological
events on a sub-cellular scale by using photocleavable cages. The development
of a system to chemically induce translation of a protein allows the combination
of these techniques.

This opens up the possibility of sub-cellular control of

specific transcripts independently of global cellular translation.

Optogenetic

control of translation could be used to investigate the role of a specific transcript
and its protein product at a given time and place.
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3.4 Methods

Materials
Restriction enzymes and polymerases were purchased from NEB.

In-

Fusion kit was purchase from Clonetech. Cell culture plates and tubes are from
Grenier-Bio One. Cell culture reagents such as media, trypsin, and PBS were
purchase from Gibco. Chemicals were purchased from Sigma unless otherwise
noted. (+)-Abscisic acid was obtained from Gold Biotechnology.

DNA Plasmids Construction
DNA primers and g-block fragments were purchased from IDT.
Ac-BoxB1-GFP – A g-block fragment was purchased containing a 70 nucleotide
spacer followed by one functional BoxB stem loop and 40 nucleotide spacer with
the following sequence
CTCAAGCTTCGAATTCTGCAGGGATCCCTGGACGGTACCCGGCTATTTAAC
CTCTTCCAACCCAAAGGCCTCTTCGAGTTCGAAGTTAACGATATCGGCGCG
CCACGCGTGATCCGGGCCCTGAAGAAGGGCCCTTTCCTTTGATCCCCCGG
GTGAAGAACCCGGGTTTCCTTTACGCGTCTCGAGTCTAGAGTCAGCTTCGA
CGAGATTTTCAGGAGCTAAGGAAGCTAAATGGCCACAACCATGGTGAGCA.
In-Fusion (Clonetech) was used to insert the fragment into Ac-ires-GFP that had
been restricted with BamHI and MscI to remove the ires fragment to produce the
vector Ac-BoxB1-GFP.
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Ac-mCherry-BoxB1-GFP- The mCherry PCR product was produced using the
primers

CCGACAGAGCTCGCCACCATGGTGAGCAAGGGCGAGGAG

and

CCGACAGGATCCTTACTTGTACAGCTCGTCCATGCC. This was ligated to the
Ac-BoxB1-GFP vector that had been restricted with SacI and BamHI to produce
Ac-mCherry-BoxB1-GFP

Ac-mCherry-BoxB2-GFP- The BoxB insert was created by annealing two
oligonucleotides
and

CGCGTGATCCGGGCCCTGAAGAAGGGCCCTTTCCTTTA

TAAAGGAAAGGGCCCTTCTTCAGGGCCCGGATCACGCG

that

were

phosphorylated on their 5’ ends. This double stranded DNA was ligated to the
Ac-mCherry-BoxB-GFP vector that had been restricted with MluI to remove the
BoxB1 region. A plasmid was selected that had two copies of the BoxB insert
and was named Ac-mCherry-BoxB2-GFP.

Ac-mCherry-MS21-GFP & Ac-mCherry-MS23-GFP– pCR4-24XMS2SL-stable
was a gift from Robert Singer (Addgene plasmid # 31865). The MS2 stem loop
sequence was created by restricting this plasmid with MluI to produce fragments
that contained the MS2 stem loop sequence. This fragment has one stem loop
sequence in the middle of the fragment and another copy that was split by the
restriction site, so that fusion of multiples of this fragment rejoined the whole
stem loop sequence. Constructs were created that had one and two copies of
the fragment and therefore had one and three copies of MS2. These constructs
were named Ac-mCherry-MS21-GFP & Ac-mCherry-MS23-GFP.
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Ac-mCherry-RL-MS23-GFP – The vector mCherry-MS23-GFP was restricted at
the AscI site just upstream of the MS2 stem loops. The restriction site was then
blunted

using

Klenow

(NEB).

The

palindromic

oligonucleotide

AAACGCCTAGGCCGGAGCGCCCAGATCTGGGCGCTCCGGCCTAGGCGTTT
with a 5’ phosphate was annealed to form the double stranded DNA that was
then ligated to the vector.

SV40-MCP-eIF4G- The MCP PCR product was created using the primers
GTATATCCATTTTCGGAATTCGCCACCATGGCTTCTAACTTTACTCAG
CCCATACAGGGGGACACGCGTGCTGCCGCCGTAGATGCCGGA

and
using

pMS2-GFP, which was a gift from Robert Singer (Addgene plasmid # 27121) as
the PCR template. In-Fusion (Clonetech) was used to insert the PCR product
into the PYL-eIF4G vector that has been restricted with EcoRI and AscI to
remove the PYL sequence and replace it with MCP.

SV40-2xMCP-eIF4G- Another MCP PCR product was created using the primer
ATCTACGGCGGCAGCGGCGCGGCCATGGCTTCTAACTTTACTCAG
with

the

same

C-terminal

primer

as

CCCATACAGGGGGACACGCGTGCTGCCGCCGTAGATGCCGGA.

along
before
In-Fusion

was used to insert the PCR product into the MCP-eIF4G vector that been
restricted with AscI to insert another MCP in between the first MCP and eIF4G.
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SV40-2xλN-eIF4G- The 2xλN fragment is a dimer of λN and was synthesized as
a

g-block

by

IDT

with

the

following

sequence,

GTATATCCATTTTCGGAATTCGCCACCATGGATGCTCAGACAAGACGCAGG
GAGAGGCGGGCCGAGAAGCAGGCCCAGTGGAAGGCCGCCAATGGCGGCA
GCGGCATGGACGCCCAGACCAGAAGAAGAGAGAGAAGAGCCGAGAAGCA
GGCCCAGTGGAAGGCCGCCAACGGCGCGCCAGGGCCCCCAAGGGGTGGG
CCAGGTGGGGAATT. In-Fusion (Clonetech) was used to insert the fragment
into the PYL-eIF4G that has been restricted with EcoRI and AscI.

SV40-PYL-eIF4G – The PYL-eIF4G construct was made by Dr. Liang and was
used as the starting point for making the direct fusion constructs.

SV40-MCP-ABI & SV40-2xMCP-ABI – The constructs were made by inserting an
ABI

fragment

created

by

using

PCR

primers

with

the

sequence

CCGACAGGCGCGCCAGTCCCCCTGTATGGGTTCACC and
CCGACAGGATCCTCACTTCAGGTCCACGACGAC. This was inserted through
ligation into the MCP-eIF4G and 2MCP-eIF4G vectors that had been restricted
with Asc1 and BamH1 to remove eIF4G.

Ac -ires-2xMCP-ABI- To get the 2xMCP-ABI product I first tried using a primer to
the

N-terminal

sequence

of

MCP,

AACACGATGATAATATGGCCAATGGCTTCTAACTTTACTCAG, but this PCR
reaction gave mostly the product with one copy of MCP. The 2xMCP-ABI product
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was produced in such low amounts from this reaction that it could not be
collected for downstream cloning. To get the 2xMCP-ABI PCR product a primer
was

designed

upstream

from

the

MS2

coding

sequence,

AACACGATGATAATATGGCCACCATTTTCGGAATTCGCCACC, that gave only
the

2xMCP-ABI

product

when

used

with

the

same

reverse

TTATGATCTAGAGTCGCGGCCGCTCACTTCAGGTCCACGACGAC

primer,
.

The

MCP-ABI and 2xMCP-ABI fragments were inserted into the Ac-ires-GFP vector
that had been restricted with MscI and NotI to remove the GFP DNA.

Ac-PYL-eIF4G-ires-2xMCP-ABI- The PYL-eIF4G PCR fragment was created
using

the

TTTGGCAAAGAATTCCTCGAGGCCACCATGACCCAGGACGAG
GGGAGGGAGAGGGGCGGATCCTCAGTTGTGGTCAGACTCCTC.

primers
and
In-Fusion

(Clonetech) was used to insert the PYL-eIF4G fragment into the plasmid Ac-ires2xMCP-ABI that was restricted with XhoI and BamHI.

Cell Culture and Transfection
B35 cells were cultured in Dulbecco’s modified Eagle’s medium (DMEM)
(Gibco) with 10% FBS (Atlanta Biologicals), 1x GlutaMAX (Gibco), and 1x
penicillin/streptomycin (Pen/Strep; Gibco). Cells (100,000) were plated in wells
of a 24well plate for 24 h before transfection. DNA constructs (0.1 µg to 0.5 µg)
were added to 50x (v/w) Opti-MEM (Gibco) and then 3x (v/w) PEI (Polysciences)
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was mixed with the DNA. The mixture was incubated for 20 min at the room
temperature before adding it to cell cultures. The cells were grown for 1 day after
transfection before experiments were performed.

Whole Well Fluorescence Measurement
Cells were harvested from 24 well plates by washing the cells from the
surface and collecting the media. Cells were spun at 3000g for 5 min at 4°C and
the media was aspirated. Cells were washed three times with PBS and spun
down at 3000g for 5 min at 4°C. The cells were resuspended in 100µL of PBS
and transferred to a black 96 well plate(Greiner Bio-One). The fluorescence of
EGFP and mCherry were analyzed using Spectra Max i3 microplate reader with
Soft Max Pro 6.3 software. EGFP fluorescence was measured using excitation
at 485nm and measuring emission at 525nm while mCherry fluorescence was
measured using excitation at 585nm and measuring emission at 625nm, Figure
3.24.

Nanometers
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Figure 3.24. The Spectra Max i3 microplate reader has tunable excitation and emission spectra.
The GFP is measured by exciting at 485nm and measuring emissions at 525nm, while the
mCherry is measured by exciting at 585nm and measuring emissions at 625nm.

Flow Cytometry Measurement
To harvest the cells from a 24 well plate the media was aspirated and cells
were incubated with 200µL 0.25% trypsin-EDTA (Gibco) for 15 minutes at 37°C.
Cells were then spun down at 3000g for 5 min at 4°C and the trypsin was
aspirated. The cells were washed with PBS and then pelleted at 3000g for 5 min
at 4°C.

The cells were fixed with 4% PFA (Sigma) for 15 minutes at room

temperature.

The cells were washed three times with PBS and then

resuspended in 150µL PBS.
The cells were analyzed using a BD Accuri C6 Plus Flow Cytometer to
measure the fluorescence of EGP and mCherry. The relative fluorescence of
EGFP was measured using the FITC channel of the flow cytometer, while the
relative mCherry fluorescence was measured using the PerCP channel of the
flow cytometer. The fluorescence is excited with a 488nm laser and data was
collected with the FL1 filter, 533/30, of the FITC channel and the FL3 filter, 670
LP, for the PerCP channel, Figure 3.25.
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Figure 3.25. The flow cytometer has an excitation laser at 488nm that excites GFP at 99.8% of
maximum and excites mCherry at 7.6% of maximum. The FL1 filter is at 533nm and has a band
width of 30nm and collects 33.7% of the GFP emission. The FL3 filter is at 670nm and is a long
pass filter and collects 20.1% of the mCherry emission.

Cells that were not transfected with the reporter construct showed most
mCherry fluorescence below 10,000. The analysis of the change in fluorescence
excluded the cells that had mCherry fluorescence below 10,000, Figure 3.26.

126

Figure 3.26. Cells were analyzed by flow cytometry based upon their GFP and mCherry
fluorescence measured with the FITC and PerCP channels respectively.

Statistics were

calculated for cells showing mCherry expression above the levels seen for the untransfected cells
(area shown in red box).

The presence of the direct fusion protein 2xMCP-eIF4G causes

translation of the GFP gene and is shifted further to the right than the negative controls.

Fluorescence Analysis
The amount of cap-dependent translation of mCherry is not affected by
the amount of cap-independent translation of a downstream gene. Therefore the
amount of mCherry expressed serves as a control for transfection and
transcription of the reporter construct and can be used as a standard to the

127

amount of EGFP produced. Thus the relative amount of translation induction is
found by dividing the EGFP fluorescence by the mCherry fluorescence.

𝑐𝑎𝑝 − 𝑖𝑛𝑑𝑒𝑝𝑒𝑛𝑑𝑒𝑛𝑡 𝑡𝑟𝑎𝑛𝑠𝑙𝑎𝑡𝑖𝑜𝑛
𝐸𝐺𝐹𝑃 𝐹𝑙𝑢𝑜𝑟𝑒𝑠𝑐𝑒𝑛𝑐𝑒
=
𝑐𝑎𝑝 − 𝑑𝑒𝑝𝑒𝑛𝑑𝑒𝑛𝑡 𝑡𝑟𝑎𝑛𝑠𝑙𝑡𝑖𝑜𝑛
𝑚𝐶ℎ𝑒𝑟𝑟𝑦 𝐹𝑙𝑢𝑜𝑟𝑒𝑠𝑐𝑒𝑛𝑐𝑒

𝑟𝑒𝑙𝑎𝑡𝑖𝑣𝑒 𝑎𝑚𝑜𝑢𝑛𝑡 𝑜𝑓 𝑡𝑟𝑎𝑛𝑠𝑙𝑎𝑡𝑖𝑜𝑛 𝑖𝑛𝑑𝑢𝑐𝑡𝑖𝑜𝑛 =

𝑐𝑎𝑝 − 𝑖𝑛𝑑𝑒𝑝𝑒𝑛𝑑𝑒𝑛𝑡 𝑡𝑟𝑎𝑛𝑠𝑙𝑎𝑡𝑖𝑜𝑛
𝑐𝑎𝑝 − 𝑑𝑒𝑝𝑒𝑛𝑑𝑒𝑛𝑡 𝑡𝑟𝑎𝑛𝑠𝑙𝑡𝑖𝑜𝑛

Taking the relative amount of cap-independent translation of the
experimental condition and dividing it by the relative amount of cap-independent
translation of the control can measure the change in cap-independent translation.
This normalizes the value and gives us the fold change in ABA inducible
translation.

𝑓𝑜𝑙𝑑 𝑐ℎ𝑎𝑛𝑔𝑒 𝑖𝑛 𝑡𝑟𝑎𝑛𝑠𝑙𝑎𝑡𝑖𝑜𝑛 =

𝑟𝑒𝑙𝑎𝑡𝑖𝑣𝑒 𝑎𝑚𝑜𝑢𝑛𝑡 𝑜𝑓 𝑡𝑟𝑎𝑛𝑠𝑙𝑎𝑡𝑖𝑜𝑛 𝑖𝑛𝑑𝑢𝑐𝑡𝑖𝑜𝑛 (𝑒𝑥𝑝𝑒𝑟𝑖𝑚𝑒𝑛𝑡𝑎𝑙)
𝑟𝑒𝑙𝑎𝑡𝑖𝑣𝑒 𝑎𝑚𝑜𝑢𝑛𝑡 𝑜𝑓 𝑡𝑟𝑎𝑛𝑠𝑙𝑎𝑡𝑖𝑜𝑛 𝑖𝑛𝑑𝑢𝑐𝑡𝑖𝑜𝑛 (𝑐𝑜𝑛𝑡𝑟𝑜𝑙)
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